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Pol II-mediated transcription and in phosphorylation-dependent regulatory
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AF4 belongs to a family of proteins implicated in childhood
lymphoblastic leukaemia, FRAXE (Fragile X E site) mental
retardation and ataxia. AF4 is a transcriptional activator that
is involved in transcriptional elongation. Although AF4 has
been implicated in MLL (mixed-lineage leukaemia)-related
leukaemogenesis, AF4-dependent physiological mechanisms
have not been clearly deﬁned. Proteins that interact with AF4
may also play important roles in mediating oncogenesis, and are
potentialtargetsfornoveltherapies.Usingafunctionalproteomic
approach involving tandem MS and bioinformatics, we identiﬁed
51AF4-interactingproteinsofvariousGeneOntologycategories.
Approximately 60% participate in transcription regulatory
mechanisms, including the Mediator complex in eukaryotic cells.
In the present paper we report one of the ﬁrst extensive proteomic
studiesaimedatelucidatingAF4proteincross-talk.Moreover,we
found that the AF4 residues Thr
220 and Ser
212 are phosphorylated,
which suggests that AF4 function depends on phosphorylation
mechanisms.WealsomappedtheAF4-interactionsitewithCDK9
(cyclin-dependent kinase 9), which is a direct interactor crucial
for the function and regulation of the protein. The ﬁndings of
the present study signiﬁcantly expand the number of putative
members of the multiprotein complex formed by AF4, which is
instrumental in promoting the transcription/elongation of speciﬁc
genes in human cells.
Key words: acute lymphoblastic leukaemia, AF4–ENL–P-TEFb
complex (AEP complex), AF4 interactome, Mediator complex,
mixed-lineage leukaemia chimaera (MLL chimaera), protein—
protein interaction, RNA polymerase II-mediated transcription
elongation.
INTRODUCTION
AF4 is the prevalent (37%) MLL (mixed-lineage leukaemia)
fusion gene associated with spontaneous acute lymphoblastic
leukaemia [1,2]. The AF4 gene transcript is ubiquitously
expressed in all types of haemopoietic cells and in other human
tissues, including brain [2,3]. The AF4 protein is a member
of the ALF [AF4/LAF4 (lymphoid nuclear protein related to
AF4)/FMR2 (Fragile X E mental retardation syndrome)] family
of nuclear proteins, which include AF4, AF5q31, LAF4 and
FMR2 [4–8]. AF4, AF5q31 and LAF4 form fusion genes with
MLL in leukaemia [9]. There are three regions that are conserved
in ALF family members: the N-terminal homology domain, the
ALF domain, which contains a proline/serine-rich region, and
the C-terminal homology domain (Figure 1) [9]. Furthermore, all
of the ALF family members, except FMR2, have a transactivation
domain [9]. The ALF domain seems to promote ALF protein
degradation through the proteasome pathway by mediating their
interaction with SIAH (seven in absentia homologue) ubiquitin
ligases [10,11]. A murine AF4-knockout model demonstrated
that AF4 is important for normal lymphocyte development and
cell growth [12]. Furthermore, Af4 was identiﬁed as the disease
gene in the robotic mouse, a dominant N-ethyl-N-nitrosourea
mutant that, in addition to defects in early T-cell maturation,
develops ataxia because of Purkinje cell degeneration in the
cerebellum [13]. This ﬁnding suggested that AF4 plays a hitherto
unknown role in a function of Purkinje cells that is essential for
the control of balance and motor co-ordination [14]. Moreover,
AF4, also through the interaction with the P-TEFb (positive
transcription elongation factor b) [15], ENL and/or AF9 [5], was
found to have transcriptional regulatory properties that entail
elongation and chromatin remodelling involving Pol II (RNA
polymerase II) [15]. Of note, the ENL family proteins ENL
and AF4 associate with DOT1L, the histone methyltransferase
that modiﬁes H3K79 and marks actively transcribed genes
[15]. A recent study demonstrated that AF4 belongs to a
higher-order multiprotein complex, which is constituted by at
least P-TEFb, ENL and AF5q31 (the ‘AEP complex’). This
multiprotein complex is recruited by wild-type MLL only on
some of its target promoters [i.e. HOXA9 (homeobox A9) and
MEIS1 (myeloid ecotropic viral integration site 1 homologue)]
[16] by context-dependent mechanisms that are still unknown.
In contrast, chimaeric oncoproteins originating from the fusion
of MLL with AEP components (MLL–AF4, MLL–AF5q31
and MLL–ENL) constitutively form hybrid complexes to cause
sustained expression of MLL-target genes that leads to leukaemic
transformation of haemopoietic cells [16].
Abbreviations used: aa, amino acids; AEP complex, AF4–ENL–P-TEFb complex; ALF, AF4/LAF4 (Lymphoid nuclear protein related to AF4)/FMR2 (Fragile
X E mental retardation syndrome); bp, base pairs; CDK9, cyclin-dependent kinase 9; CTD, C-terminal domain; ECL, enhanced chemiluminescence; ELL,
eleven-nineteen lysine-rich leukaemia; EAF1, ELL-associated factor 1; FBS, fetal bovine serum; FMR2, Fragile X E mental retardation syndrome; HEK,
human embryonic kidney; HOXA9, homeobox A9; HPRD, Human Protein Reference Database; LAF4, lymphoid nuclear protein related to AF4; LC-ESI,
liquid chromatography-electrospray ionization; MCM, minichromosome maintenance; MED, Mediator complex subunit; MLL, mixed-lineage leukaemia;
MS/MS, tandem MS; PICM, protease inhibitor cocktail for mammalian tissues; Pol II, RNA polymerase II; P-TEFb, positive transcription elongation factor b;
SEC, super elongation complex; SIAH, seven in absentia homologue; WCE, whole cell extract.
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Figure 1 Schematic representation of the ﬂagged AF4 constructs used in the present study
The various known protein domains are shown.
In the present study, we used functional proteomics procedures
to look for proteins that interact with human AF4 in an attempt
to gain further insights into its function and the regulatory
mechanism in which it is involved in physiological, as well as
in pathological, transcriptional pathways.
EXPERIMENTAL
Plasmids
The full-length AF4 cDNA (GenBank® accession number
NM_005935) and partial AF4 cDNAs, designated AF4-1 [bp
(basepairs)4–1950;aa(aminoacids)2–650],AF4-1.1(bp4–833;
aa 2–277), AF4-1.2 (bp 696–1497; aa 232–499) and AF4-1.3 (bp
1384–1950; aa 462–650), were cloned into the N-terminal p3X-
FLAG7.1vector(Sigma–Aldrich),toobtainrecombinantproteins
tagged with a FLAG epitope at the N-terminus (Figure 1). Primer
sequences and cycling conditions are available upon request from
the corresponding author.
Antibodies
The antibodies usedwere: mouse monoclonalanti-FLAG M2 and
anti-α-tubulin (Sigma–Aldrich); rabbit polyclonal anti-AF4 for
immunoprecipitation and anti-AF4 for Western blotting (Bethyl
Laboratories); rabbit polyclonal anti-CDK9 (cyclin-dependent
kinase 9), anti-ELL (eleven-nineteen lysine-rich leukaemia),
anti-YWHAQ, anti-YWHAE, anti-MED1 (MED is Mediator
complex subunit) (Santa Cruz Biotechnology); goat polyclonal
anti-MED7, anti-CRSP3 (also known as MED23), anti-SIAH-1,
anti-MED27, anti-MED24, anti-MED17, anti-MED6 and anti-
MED26 (Santa Cruz Biotechnology); anti-mouse and anti-rabbit
secondary antibodies (GE Healthcare); and anti-goat secondary
antibody (Santa Cruz Biotechnology).
Cell culture and transfection
HEK (human embryonic kidney)-293 cells (A.T.C.C. number
CRL-1573) were grown in DMEM (Dulbecco’s modiﬁed Eagle’s
medium; Lonza), supplemented with 10% FBS (fetal bovine
serum; Lonza) and 10 ml/l penicillin/streptomycin (Sigma–
Aldrich). Cells were seeded for 24 h before transfection
at approximately 6×10
4/cm
2 conﬂuency and transfected for
48 h using the calcium phosphate method. 697 cells (human
pre-B lineage leukaemia) [DSMZ (Deutsche Sammlung von
Mikroorganismen und Zellkulturen) number ACC 42] were
culturedinRPMI1640medium(Lonza)supplementedwith20%
FBS (Lonza), 2 mM L-glutamine (Sigma–Aldrich) and 10 ml/l
penicillin/streptomycin (Sigma–Aldrich).
Cell lysis, protein extraction and immunoprecipitation
HEK-293 cells were transfected with either a recombinant or
empty vector (mock control) and lysed in immunoprecipitation
buffer A [10% glycerol, 50 mM Tris/HCl (pH 8), 150 mM
NaCl, 0.1% Nonidet P40, 0.5 M EDTA and 10 μl/ml PICM
(protease inhibitor cocktail for mammalian tissues; Sigma-
Aldrich)]. 697 cells were lysed in immunoprecipitation buffer
B [50 mM Tris/HCl (pH 8), 150 mM NaCl, 10 mM KCl, 1.5 mM
MgCl2, 10 mM sodium ﬂuoride, 1.5 mM MgCl2, 1 mM sodium
orthovanadate, 0.2 mM EDTA, 0.5% Nonidet P40 and 10 μl/ml
PICM].
For the FLAG immunoprecipitation assays, the lysate was
incubated for 1 h at 4◦C with anti-FLAG M2–agarose afﬁnity
gel (Sigma–Aldrich) using 40 μl per 10 mg of total proteins.
Immunocomplexes were eluted from the anti-FLAG afﬁnity gel
using 1 μl of elution buffer [immunoprecipitation buffer A with
200 μg/ml3X-FLAGpeptide(Sigma–Aldrich)]per μlofgel.F or
theimmunoprecipitationassaysusingspeciﬁcantibodiesdirected
against endogenous interactors, lysates either from transfected
HEK-293 or 697 cells were incubated overnight at 4◦C with
1–3 μg of a speciﬁc antibody, i.e. anti-MED7, anti-CRSP3, anti-
CDK9, anti-ELL, anti-YWHAQ, anti-YWHAE or anti-SIAH-1
and, only for lysate from 697 cells, anti-AF4 antibody for
immunoprecipitation, per 10 mg of total proteins. Subsequently,
the mixture from HEK-297 cells was incubated with 30 μlo f
ProteinA/GPLUS–agarose(SantaCruzBiotechnology)per1 μg
of antibody, and the immunocomplexes were washed several
times with immunoprecipitation buffer A. Otherwise, the mixture
from 697 cells was incubated with 5 μl of Protein A–Sepharose
4 Fast Flow (GE Healthcare) per 1 μg of antibody, and the
Sepharose-bound immunocomplexes were washed several times
with immunoprecipitation buffer B. As a negative control, we
used cell extracts incubated with serum IgGs (goat or rabbit,
Sigma–Aldrich), processed in a similar manner to the samples.
Western blot analysis
Either 40 μg of WCE (whole-cell extract) from HEK-293
cells, or 40 μgo fW C Ef r o m6 9 7c e l l s ,o r1 5 μlo fs a m p l e
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from each immunoprecipitation experiment were loaded on
to SDS/PAGE and then transferred on to a nitrocellulose
membrane for Western blot analysis. Blots were incubated
with the following primary antibodies: anti-FLAG-M2 (1:5000
dilution)oranti-α-tubulin(1:1000dilution);anti-AF4forWestern
blotting (1:8000 dilution); anti-CDK9, anti-YWHAQ, anti-
YWHAE, anti-SIAH-1 (all at a 1:1000 dilution); anti-ELL (1:500
dilution); anti-MED1, anti-MED7, anti-CRSP3, anti-MED27,
anti-MED24, anti-MED17, anti-MED6 and anti-MED26 (all
at a 1:200 dilution). Membranes were then incubated with
HRP (horseradish peroxidase)-conjugated appropriate secondary
antibodies, i.e. anti-mouse or anti-rabbit (1:5000 dilution) or anti-
goat (1:8000 dilution). The bands were visualized with the ECL
(enhanced chemiluminescence) or ECL Plus detection system
(GE Healthcare).
Preparative immunoafﬁnity puriﬁcation
AF4-1-interacting proteins were puriﬁed using anti-FLAG-M2
afﬁnity gel (Sigma–Aldrich) (as described above) on 50 mg of
WCE from HEK-293 cells transfected with the FLAG–AF4-1
construct. The same puriﬁcation protocol was also carried out
with an equal amount of extract from HEK-293 cells that
were transfected with the empty p3X-FLAG vector (mock
control). The proteins eluted from the agarose beads were
chloroform/methanol-precipitatedandthepelletsweredried[17].
SDS/PAGE, in-gel digestion and MS analysis
The protein pellets obtained by afﬁnity puriﬁcation from
transfected and from mock control cells were resuspended
in SDS/PAGE buffer and fractionated by SDS/PAGE (10%
gels). Protein electrophoretic patterns were visualized using Gel
Code Blue Stain Reagent (Pierce). The two gel lanes were
cut to generate 38 slices (∼2 mm) per lane. Subsequent in-gel
digestion and nano-LC-ESI (liquid chromatography-electrospray
ionization)-MS/MS (tandem MS) analyses of each of the protein
slices was performed as described previously [18,19].
Raw data from nano-LC-ESI-MS/MS analyses were converted
into a peak list by using LC-MSD Trap 6.0 Build 485.0 (Agilent
Technologies) to create a Mascot format text. Proteins were
identiﬁed in-house by means of Mascot software version 2.1
(Matrix Science) [20]. The protein search was governed by
the following parameters: non-redundant protein sequence data
base (NCBInr, July 2009 – 20070908 database with 7415798
sequences and 2558340887 residues downloaded; Sprot, July
2009 – 57.6 database with 495880 sequences and 174780353
residues downloaded; the protein sequence entries actually
searched numbered 187996 for NCBInr and 20331 for Sprot
because of the taxonomy restriction to Homo sapiens); speciﬁcity
oftheproteolyticenzymeusedforhydrolysis(trypsin);taxonomic
category of the sample (H. sapiens); no protein molecular mass
was considered; up to one missed cleavage; carbamidomethyl
cysteinewassetasaﬁxedmodiﬁcation,andproteinN-acetylation,
N-terminal pyroglutamate, oxidized methionine residues, and
phosphorylation of serine, threonine or tyrosine were set as
variable modiﬁcations; a precursor peptide maximum mass
tolerance of 100 p.p.m. and a maximum fragment mass tolerance
of 150 p.p.m. According to the probability-based Mowse score
[20], the ion score is −10×Log(P), where P is the probability
that the observed match is a random event. Individual scores >38
indicate identity or extensive homology (P<0.05). Individual
MS/MS spectra for peptides with a Mascot score equal to 38
were inspected manually. All of the peptides were inspected
for redundancy and represent sequences that are unique within
the database used. Phosphopeptide spectra with a minimum
Mascotscoreof38(P<0.05)wereconsideredforfurthermanual
data interpretation. Phosphorylation site assignments by Mascot
were validated and veriﬁed manually using the MS-Product
tool (University of California San Francisco, Mass Spectrometry
Facility, http://prospector.ucsf.edu/) with loss of H3PO4 and
multiple losses enabled as an additional option, focusing on
the occurrence of b-a n dy-ions, internal fragments, and neutral
losses of H2O, NH3 or H3PO4 from these ions and the parent ion
respectively.
In silico analysis
To deﬁne an in silico ‘interactome’ map of AF4, we screened
the HPRD (Human Protein Reference Database; freely available
at http://www.hprd.org) for AF4 interactions [21]. We created
a list of the known protein–protein interactions of AF4, and a
list of primary (direct) and secondary (indirect) interactions was
reported for each identiﬁed protein. In April 2011, the HPRD
database contained 30047 human protein entries, 39194 protein–
protein interactions and 453521 PubMed links. We used the
HPRD, the BIND (Biomolecular Interaction Network Database;
http://bond.unleashedinformatics.com/Action), DAVID bioin-
formatics resources (http://www.david.abcc.ncifcrf.gov) and
STRING (http://string.embl.de) for protein clustering.
Supporting information available (http://www.BiochemJ.org/bj/
438/bj4380121add.htm)
Identiﬁcation of AF4-1-interacting proteins by nanoLC/ESI-
MS/MS, along with identiﬁed peptide sequences, precursor mass,
charge state, mass errors, single peptide MASCOT score and
sequencecoverage(SupplementaryTableS1).Analysisofcontrol
lane by nanoLC/ESI-MS/MS, along with identiﬁed peptide
sequences, precursor mass, charge state, mass errors, single
peptide MASCOT score, sequence coverage (Supplementary
Table S2). Conﬁrmation of identiﬁed phosphorylation sites
(Supplementary Table S3). In silico analysis of AF4 interactors
by the Human Protein Reference Database (http://www.hprd.org)
(Supplementary Table S4).
RESULTS AND DISCUSSION
We have used a functional proteomics approach to identify,
in the HEK-293 cell line, proteins that interact with AF4, a
member of the ALF family that supplies most of the partners
of the oncogenic fusion proteins involved in childhood acute
lymphoblastic leukaemia [1]. The present study represents one
of the ﬁrst global functional proteomic analyses to determine the
identity of proteins that form a multimeric complex with AF4.
In contrast with HeLa, SAOS, K562 and SK-NB-E cell
lines, the human HEK-293 cell line efﬁciently expressed our
‘baits’, the recombinant proteins FLAG–AF4-1 and FLAG–AF4
(Figure 1). Moreover, as reported in the HPRD and Unigene
databases, the AF4 transcript is expressed in kidney, and HEK-
293 cells have served previously as a heterologous expression
system to study mouse recombinant AF4 [15]. We transfected
HEK-293 cells with the full-length AF4 and with the AF4-1
cDNA constructs (Figure 2A). Co-immunoprecipitation with the
ﬂaggedfull-lengthAF4proteinyieldedproteinamountsthatwere
sufﬁcient for Western blot analysis, but not for an exhaustive
functionalproteomicanalysis.Consequently,weusedtheFLAG–
AF4-1 construct for large-scale immunoafﬁnity puriﬁcation, and
then validated the results in Western blot experiments with the
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Figure 2 Expression of ﬂagged proteins and afﬁnity co-
immunoprecipitations
(A) Western blot analysis of recombinant AF4 polypeptides expressed in WCE from HEK-293
cells. An extract from cells transfected with the empty 3X-FLAG vector was used as a
mock control. (B) Proteins from total lysate of HEK-293 cells transfected with FLAG–AF4-1
were immunoprecipitated using anti-FLAG agarose beads (IP FLAG). The FLAG–AF4-1
immunocomplex was in part separated by SDS/PAGE (10% gel) (left-hand panel, colloidal
Coomassie Blue staining) and in part immunoblotted with an anti-FLAG monoclonal antibody
(right-hand panel). In both cases, an immunoprecipitate from cells transfected with empty
3X-FLAG vector was used as a mock control. The molecular mass in kDa is indicated on the
left-hand side. IP, immunoprecipitation; WB, Western blot.
full-length recombinant protein. It is of note that FLAG–AF4-
1 encodes the N-terminal half of the protein containing the
transactivationdomain(Figure1),butnotthebindingdomainsfor
AF9 and ENL, the other two most common MLL fusion partners
[22].
Proteins from total lysates of HEK-293 cells transfected with
FLAG–AF4-1 and with the empty vector (mock control) were
immunoprecipitated,andimmunocomplexeswerefractionatedby
SDS/PAGE (10% gels) (Figure 2B). From each gel lane, we
obtained 38 peptide mixtures, each of which was analysed in
duplicate by MS. Peptide mixtures from the control lane were
always injected before peptides from the sample lane to avoid
carry-over.
Our analysis, although unable to distinguish between direct
and indirect interactors, revealed 51 proteins, most of which
were not previously known to be molecular partners of AF4.
They are listed in Table 1, grouped according to their function.
Supplementary Table S1 (at http://www.BiochemJ.org/bj/438/
bj4380121add.htm) shows, for each protein entry, the peptide
sequence identiﬁed, the precursor mass (m/z), the charge state
(z), the mass errors (p.p.m.) on the precursor peptide, the Mascot
score for each peptide and the protein sequence coverage. Each
protein is reported only with the gene symbol from NCBI source
to eliminate redundancy.
To select proteins that speciﬁcally interact with AF4-1, we
subtracted species that were common to AF4-1 and non-
transfectedcontrollanes(Figure2B).Thesecommonproteinsare
shown in Supplementary Table S2 (at http://www.BiochemJ.org/
bj/438/bj4380121add.htm). All protein species identiﬁed by a
single peptide were checked further. First, the peptide sequence
stretchwasmanuallyreconstructed,andthenthepeptidesequence
and the peptide precursor ion mass were inserted into the
Mascot software using the sequence query mode. All searches
were performed against the NCBInr and Sprot databases. The
peptide sequence was searched for using BLAST software
(http://ncbi.nlm.nih.gov/blast). Supplementary Table S1 shows
the full MS scan and the properly annotated MS/MS scan (with
masses and fragment assignments) of proteins identiﬁed by a
single peptide.
We classiﬁed the human proteins identiﬁed according to their
Gene Ontology cellular localization (Figure 3A) and to the
biological processes in which they are involved (Figure 3B). It
is of note that the nature of the identiﬁed proteins, which are
mainly localized in the nucleus (68%), points to the existence of
a large protein network involving AF4. Approximately 60% of
the proteins identiﬁed that take part in this cross-talk are clustered
in the Pol II transcriptional complex.
To check the authenticity of the AF4-interacting proteins
identiﬁed by MS/MS, we veriﬁed the presence of some of these
proteins by anti-FLAG co-immunoprecipitation and Western
blot analysis, depending on the availability and efﬁciency of
commercialantibodies.WeconﬁrmedthatCRSP3/MED23,ELL,
CDK9, CRSP33/MED7, YWHAQ and YWHAE speciﬁcally
interact with AF4-1 and with the full-length AF4 (Figure 4A),
thus demonstrating that the latter two, despite their difference in
length,havesimilarfoldingincommonregions.Wealsoidentiﬁed
SIAH-1, a known molecular direct interactor of AF4 [10,11]
(Figure 4A). We validated the AF4 interactors further by reverse
immunoprecipitationexperimentsusingspeciﬁcanti-CDK9,anti-
YWHAQ, anti-CRSP3, anti-MED7, anti-ELL and anti-YWHAE
antibodies on extracts from HEK-293 cells transfected with
FLAG–AF4. Western blot analysis with the anti-FLAG antibody
revealed the FLAG-tagged protein in each immunocomplex
(Figure 4B). These interactions were also conﬁrmed by Western
blotanalysisofimmunocomplexesobtainedfromproteinextracts
of an haemopoietic cell line, the human pre-B lineage leukaemia
697 cells, by using speciﬁc antibodies directed against either
endogenous AF4 or endogenous interactors (Figure 5). Overall,
our immunoprecipitation experiments support the conclusion that
endogenous CDK9, YWHAQ, CRSP3/MED23, CRSP33/MED7,
ELL and YWHAE interact with FLAG–AF4 in HEK-293 cells,




namely CRSP8/MED27, THRAP4/MED24, PPARBP/MED1,
CRSP6/MED17, MED6 and CRSP7/MED26. However, these
antibodies failed to detect the respective target proteins in cellular
extracts from HEK-293, HeLa, SAOS, SK-NB-E, K562 or 697
cells analysed by Western blotting (results not shown).
c   The Authors Journal compilation c   2011 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.The human AF4 protein network 125
Table 1 AF4-1-interacting proteins identiﬁed by nano-LC-ESI-MS/MS and their Gene Ontology classiﬁcation
Gene symbol Accession number Protein
Transcription-regulatory proteins
PPARBP, MED1 gi|2765322 Activator-recruited cofactor 205kDa component
MED12 gi|4827042 Mediator of RNA polymerase II transcription, subunit 12 homologue
CRSP2, MED14 gi|4580326 Cofactor required for Sp1 transcriptional activation, subunit 2, 150 kDa
CRSP3, MED23 gi|28558969 Cofactor required for Sp1 transcriptional activation, subunit 3, 130 kDa
THRAP4, MED24 gi|8699628 Vitamin D receptor-interacting protein complex component DRIP100
CRSP6, MED17 gi|28558975 Cofactor required for Sp1 transcriptional activation, subunit 6, 77 kDa
CRSP7, MED26 gi|28558977 Cofactor required for Sp1 transcriptional activation, subunit 7, 70 kDa
RBBP4 gi|13111851 Retinoblastoma-binding protein 4
RUVBL2 gi|13111851 48kDa TATA-box-binding protein-interacting protein
EAF1 gi|27370592 ELL-associated factor 1
MED4 gi|7141320 p36 TRAP/SMCC/PC2 subunit (Mediator of RNA Pol II transcription, subunit 4 homologue)
CRSP8, MED27 gi|7141322 Cofactor required for Sp1 transcriptional activation, subunit 8, 34 kDa
MED7 gi|13528909 Cofactor required for Sp1 transcriptional activation, subunit 9
MED6 gi|3329506 RNA polymerase transcriptional regulation mediator
MED8 gi|33988564 Mediator of RNA polymerase II transcription subunit 8 activator-recruited cofactor 32kDa component
TRFP, MED20 gi|4323033 Trf (TATA binding protein-related factor)-proximal homologue
MED21 gi|1515377 RNA polymerase II holoenzyme component SRB7
ELL gi|10130023 RNA polymerase II elongation factor ELL
PCQAP gi|14043091 MED15
TCEA1 gi|313223 Transcription elongation factor A (SII), 1
DNA-directed RNA polymerase proteins
POLR2A gi|36124 RNA polymerase II largest subunit
POLR2B gi|4505941 RNA polymerase II second largest subunit
POLR2C gi|2920711 Polymerase (RNA) II (DNA-directed) polypeptide C, 33kDa
DNA-binding proteins
MCM3 gi|1552242 DNA polymerase α-holoenzyme-associated protein P1 (p102 protein)
RUVBL1 gi|15277588 49kDa TATA box-binding protein-interacting protein
RNA-binding proteins
NCL gi|189306 Nucleolin
PRPF31 gi|40254869 PRP31 pre-mRNA processing factor 31 homologue
SNRPD2 gi|29294624 Small nuclear ribonucleoprotein D2 polypeptide 16.5 kDa
Serine/threonine kinase protein
CDK9 gi|12805029 Cyclin-dependent kinase 9 (CDC2-related kinase)
Serine/threonine phosphatase protein
PPP2R1A gi|178663 Protein phosphatase 2 (formerly 2A) regulatory subunit A (PR 65) α isoform
Translation regulator protein
EEF1B2 gi|12652911 Eukaryotic translation elongation factor 1 β1
Auxiliary transport protein
GDI2 gi|285975 Rab GDP dissociation inhibitor β
Receptor signalling complex scaffold proteins
YWHAE gi|12655169 14-3-3 protein, ε isoform (protein kinase C inhibitor protein 1)
YWHAQ gi|55594676 14-3-3 protein θ (14-3-3 protein T-cell)
SPIN gi|5730065 SPINL
AP3S1 gi|4502861 Adapter-related protein complex 3 σ1 subunit
Signal transduction proteins
CCNT1 gi|2981196 CDK9 associated C-type cyclin
S100A8 gi|21614544 S100 calcium-binding protein A8
S100A9 gi|4506773 S100 calcium-binding protein A9
Transmembrane receptor protein tyrosine kinase protein
FGFR2 gi|29432 Fibroblast growth factor (FGR) receptor
Lipid kinase proteins
PIP5K2B gi|1857637 Phosphatidylinositol-4-phosphate 5-kinase type II, β
PIP5K2C gi|21322230 Phosphatidylinositol-4-phosphate 5-kinase, type II, γ
Heterotrimeric G-protein GTPase protein
GNB4 gi|12654119 Guanine-nucleotide-binding protein (G-protein), β polypeptide 4
Guanyl-nucleotide exchange factor protein
ARHGEF4 gi|8809845 Rho guanine-nucleotide-exchange factor (GEF) 4
Enzyme: dehydrogenase
GAPDH gi|31645 Glyceraldehyde-3-phosphate dehydrogenase
Enzyme: synthase
PTS gi|4506331 6-pyruvoyltetrahydropterin synthase
Unknown
SMAD9 gi|13959539 MAD mothers against decapentaplegic homologue 9
LSM14A gi|16877144 LSM14 homologue A (RNA-associated protein 55)
DRG1 gi|17939479 Developmentally regulated GTP-binding protein 1 (neural precursor cell expressed developmentally
down-regulated 3)
HCCA2 gi|55249549 HCCA2 protein (MOB2)
C20orf11 gi|21594655 Chromosome 20 open reading frame 11
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Figure 3 Classiﬁcation of the identiﬁed proteins
(A) According to Gene Ontology Cellular Localization and (B) Biological Processes.
It is of note that in our system we did not identify all of
the proteins previously reported to interact with AF4. This is
probably due to the use of the N-terminal half of AF4 as ‘bait’.
In fact, we did not ﬁnd AF9, ENL, DOT1L or AF5q31, the AF4
partners known to interact with its C-terminal half [23]. However,
although our bait (FLAG–AF4-1) lacks the crucial C-terminal-
binding domain, we were able to identify various known and
new molecular partners, thereby providing further insight into
AF4 function in normal and leukaemic conditions. Obviously
we cannot exclude that some of the reported interactions may
be cell-lineage speciﬁc; however, almost all of the proteins that
form the AF4 interactome, as well as AF4 itself, are variably
expressedinvariouscelltypes,accordingtotheUniGenedatabase
(http://www.ncbi.nlm.nih.gov/unigene).
AF4 is a phosphorylated protein [15], but its phosphorylation
sites are still unknown. LC-MS/MS analysis of the bait protein
revealed two phosphorylation sites (Figure 2B). The MS2
spectra from the identiﬁed phosphopeptides are shown in
Figure 6. Peptide ELSPLISLPSPVPPLSPIHSNQQTLPR turned
out to be phosphorylated on Thr
220 and Ser
212 (Figures 6A
and 6B respectively). We also identiﬁed the corresponding
unmodiﬁed peptide (Figure 6C). The phosphorylation sites
identiﬁed were manually conﬁrmed (Supplementary Figure S1 at
http://www.BiochemJ.org/bj/438/bj4380121add.htm). Although
this peptide was previously reported to be phosphorylated [24],
we indicate for the ﬁrst time the precise localization of the
phosphorylation sites.
To extend our data, we carried out an in silico proteomic
analysis of proteins that are known to directly or indirectly
interact with AF4. Examination of the HPRD indicated two
Figure 4 FLAG–AF4 associates with CRSP3, MED7, ELL, CDK9, SIAH1,
YWHAQ and YWHAE
(A) Proteins from total lysate of HEK-293 cell lines transfected respectively with FLAG–AF4,
FLAG–AF4-1 and empty vector (mock control) were immunoprecipitated using anti-FLAG
agarose beads, then resolved by SDS/PAGE (10% gel) and analysed by Western blotting
with speciﬁc antibodies. (B) Proteins from WCE of HEK-293 cells transfected respectively with
FLAG–AF4andemptyvector(mockcontrol)wereimmunoprecipitatedusingspeciﬁcantibodies,
then resolved by SDS/PAGE (8% gel) and analysed by Western blotting with an anti-FLAG
antibody.ThemolecularmassinkDaisindicatedontheleft-handside.IP,immunoprecipitation.
direct interactions for AF4: SMAD9 and ENL [23,25]. In the
present study, we identiﬁed SMAD9, also known as SMAD8A
or SMAD8B (Table 1 and Supplementary Table S1). We
carried out a detailed clustering analysis using the HPRD to
look for a protein network involved in the same functional
scenario. To this aim, we ﬁlled out a comprehensive list of
known primary and secondary interactions for all proteins
found in the present study (see Supplementary Table S3 at
http://www.BiochemJ.org/bj/438/bj4380121add.htm).
Several proteins reported in the present study interact with
each other, thus suggesting that they participate in the same
multiprotein complex or complexes. Thevast majority of proteins
interacting with human AF4 are involved in Pol II-mediated
transcription. Thus there is compelling evidence that AF4 plays
a key role in the Pol II transcription machinery. Figure 7 shows a
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Figure 5 Endogenous AF4 associates with CRSP3, MED7, ELL, CDK9, SIAH1, YWHAQ and YWHAE
Proteinsfromtotallysatesof697celllineswereimmunoprecipitated(IP)usinganti-AF4,anti-CDK9,anti-YWHAQ,anti-CRSP3,anti-MED7,anti-ELLandanti-YWHAEantibodies.Immunocomplexes
were resolved by SDS/PAGE (10% gel) and analysed by Western blotting with speciﬁc antibodies. WCE represents the control and IgG the mock. The molecular mass in kDa is indicated on the
left-hand side.
map of the AF4-interacting proteins, with Pol II as the core of the
interactions.
Indeed, our proteomics analysis identiﬁed the serine/threonine
kinase CDK9 and cyclin T1 (CCNT1) that interact each other and
form the positive transcription elongation factor P-TEFb, which
activatethePolIIelongationmachinery[26].ItisknownthatAF4
associates with P-TEFb, positively regulates its kinase activity
and stimulates Pol II transcriptional elongation [15]. Through its
ability to phosphorylate the Pol II CTD (C-terminal domain), P-
TEFb controls productive elongation of most eukaryotic genes,
but also co-ordinates downstream events including pre-mRNA
splicing and 3
 -end processing [27]. P-TEFb recruits various
positive regulators other than AF4, namely, the transcriptional
activators HIV Tat, CIITA, c-Myc, NF-κB (nuclear factor κB),
MyoD, Brd4, AF5q31 and ELL to speciﬁc gene promoters
and stimulates transcriptional elongation [16,26,28,29]. A recent
paper demonstrate that AF4, AF5q31 and ENL associate in
an endogenous higher-order complex containing P-TEFb in
haemopoietic lineage cells [16]. Our results indicate that such
a complex should also be formed in HEK-293 cells. Therefore
we mapped the CDK9-binding region along AF4. To this aim,
we produced three new ﬂagged constructs, namely AF4-1.1 (bp
4–833), AF4-1.2 (bp 696–1497) and AF4-1.3 (bp 1384–1950)
(Figure 1), which we used to transiently transfect HEK-293 cells.
We analysed the corresponding anti-FLAG immunoprecipitates
by Western blotting with the anti-CDK9 antibody (Figure 8) and
found that, in agreement with Yokoyama et al. [16], only AF4-
1.1 (aa 2–277) was able to interact with CDK9. Intriguingly,
this peptide contains Ser
212 and Thr
220, which we found to be
phosphorylated in our structural characterization of AF4.
P-TEFb phosphorylates AF4 and down-regulates its
transactivation activity [15]. Therefore phosphorylation is a key
control mechanism of AF4 activity, and the AF4 N-terminal
region might reasonably be the P-TEFb phosphorylation site.
This type of control should thus be ineffective on MLL–AF4
chimaeras that lack the AF4 N-terminus. It is notable that,
phosphorylationeventsregulate thefunctionofothercomponents
thatweidentiﬁedintheAF4proteinnetwork[e.g.14-3-3proteins,




elongates [30]. Elongation is inﬂuenced by the P-TEFb-mediated
phosphorylation of the CTD of the largest Pol II subunit [31].
In agreement with our present study and with reports from other
groups showing that AF4 directly interacts with P-TEFb [15,16],
weidentiﬁedintheAF4multiproteincomplex,thelargestsubunit
(POLR2A), the second largest subunit (POLR2B) and a small
subunit of 33 kDa (POLR2C) of Pol II. In addition, we found:
(i) nucleolin, which forms complexes with POLR2A, CDK9
and CCNT1, and plays a role in transcriptional elongation [32];
(ii) TCEA1 (transcription elongation factor A), another Pol II
transcription elongation factor, which has a role in suppression
of transient pausing and strongly synergizes with p300 histone
acetylase at a step subsequent to pre-initiation complex formation
[33]; and (iii) MCMs, a family of proteins related to ATP-
dependent helicases, which has been co-puriﬁed with Pol II after
anti-MCM3 immunoafﬁnity chromatography [34]. The results
of the present study support the idea that MCM proteins are
components of the Pol II transcriptional apparatus [34].
We also found that AF4-1 interacts with the Pol II elongation
factor ELL that, as well as AF4, ENL and AF5q31, is frequently
fused to MLL in childhood lymphoblastic leukaemia [34]. ELL
is a multifunction factor that exerts transcriptional elongation
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Figure 6 MS/MS spectra of modiﬁed and unmodiﬁed peptides of AF4
(A) MS/MS spectrum of ELSPLISLPSPVPPLSPIHSNQQpTLPR; (B) MS/MS spectrum of
ELSPLISLPSPVPPLpSPIHSNQQTLPR; (C) MS/MS spectrum of ELSPLISLPSPVPPLSPIHS-
NQQTLPR.  indicates the m/z signal of the parent ion.
activity and inhibitory effects on the initiation of Pol II-mediated
transcription [35,36], besides acting as a transcription factor
[37]. In particular, the CTD of ELL interacts with P-TEFb [36],
a molecular interactor of the N-terminal domain of AF4, as
we demonstrate in the present study. Our proteomic analysis
also identiﬁed EAF1 (ELL-associated factor 1) [38]. EAF1
Figure 7 Map of protein–protein interactions
All proteins identiﬁed in the present study are reported in the map that was obtained using
the open-source software STRING. AF4 protein is not included. The purple lines indicates
interactions proved by in vitro and/or in vivo assay and previously reported in the literature
(PubMed); the blue lines show proteins that participate in the same complex, as reported
in the well-annotated databases HPRD, Database of Interacting Proteins (DIP) and BioGrid
(http://www.thebiogrid.org/).Thephysicaldistancebetweentwoproteins(nodes)alonganedge
in a graph has no meaning.
interaction with the CTD of ELL is necessary and sufﬁcient for
the leukaemogenic effect of the MLL–ELL fusion protein [38].
Notably, a heterologous MLL–EAF1 fusion protein recapitulates
the phenotype of MLL–ELL in vitro and in vivo [38]. EAF1 is a
strong positive regulator of ELL elongation activity and contains
a transactivation domain that has high sequence identity with the
transactivation domain of AF4 [38]. Therefore it is not surprising
that the latter may also associate with ELL and positively regulate
its transactivating function [38,39]. The identiﬁcation of ELL
and EAF1 among AF4 interactors is in line with a recent
report demonstrating that ELL and EAF1 are part of a SEC
(super elongation complex), which includes P-TEFb, AF5q31,
ENL and AF4, that is crucial in the control of transcription
elongation[40].Suchacomplexshouldberecruitedconstitutively
by MLL chimaeras that should thus be able to bypass the
normal transcription initiation and elongation checkpoint steps,
andactivateaberrantMLL-targetgeneexpression[16,40].Indeed,
knockdown of the central SEC component AF5q31 in MLL–AF4
leukaemia cells causes a reduction in the expression of HOXA9,
a key mediator of leukaemogenesis [40].
Although we cannot be sure about the interactions that were
not validated with immunoprecipitation/Western blot methods,
the data discussed so far demonstrate the appropriateness of our
proteomic approach. In fact, all the interactions we identiﬁed are
in line with the most recent ﬁndings about the composition of the
multiprotein complex involving AF4 [16,40]. Indeed, the ﬁnding
of Pol II subunits in this complex supports the crucial role of
AF4 in the transcriptional machinery. However, the novelty of
the present study resides in the identiﬁcation of 15 out of the 28
proteins that form the mammalian Mediator complex (Table 1).
The Mediator complex is a multiprotein transcription factor
that is evolutionarily conserved and ubiquitously expressed in
eukaryotes from yeast to man [41,42]. This large multisubunit
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Figure 8 CDK9 interacts with the N-terminal region of AF4 (aa 2–277)
Proteins from total lysate (WCE) of HEK-293 cell lines transfected respectively with three
constructs coding for different regions of AF4-1 fragment (see Figure 1) and with empty
vector (mock control) were immunoprecipitated (IP) using anti-FLAG antibodies, resolved by
SDS/PAGE (12% gel) and analysed by Western blotting with an anti-CDK9 antibody. The
molecular mass in kDa is indicated in the left-hand side.
complex is the primary regulator of the assembly of the pre-
initiation complex, which includes the general transcription
factors TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIE and Pol II
[41–43].Ingeneral,transcriptionfactorsandactivatorsphysically
bind to a speciﬁc subunit of Mediator and thereby recruit
other components of the complex to the target promoter. In
particular, activator binding provokes speciﬁc conformational
shifts in Mediator that induce a conformational state in the
neighbouring subunits of the complex. Indeed, Mediator can
adopt various conformations after the binding of different
transcriptional activators to different Mediator subunits [44].
Therefore structural changes in Mediator afford additional
opportunities to ﬁne-tune the diverse regulatory inputs received
from the DNA-binding factors and from other signals to the
transcription machinery [45]. Genetic, biochemical and structural
data revealed that Mediator comprises several modules (head,
middle, tail and CDK8) [46]. The head, middle and tail modules
form a relatively stable ‘core’ that is composed of 18–20
tightly associated subunits [40,45]. Otherwise, the subunits
PPARBP/MED1,MED25andMED8,andthemoduleconstituted
by CRSP3/MED23, THRAP4/MED24 and TRAP95/MED16 are
variably and weakly associated with the central core [40]. The
constant core and the variably associated proteins are considered
to be components of the active forms of the Mediator complex.
In contrast, SRB10/CDK8, MED13, MED12 and SRB11/CycC
(cyclin C) form a functional and physically separable module that
has been implicated in transcriptional repression [40,45]. The
potential microheterogeneity could result in a wide spectrum of
mammalian Mediator complexes [47].
Our proteomic analysis of the AF4 complex identiﬁed ten
Mediator central core subunits (TRAP36/MED4, TRAP32/
MED6, CRSP33/MED7, CRSP2/MED14, CRSP6/MED17,
TRFP/MED20, MED21, CRSP7/MED26, PCQAP/MED15 and
CRSP8/MED27) and four variable subunits (PPARBP/MED1,
MED8, CRSP3/MED23 and THRAP4/MED24). Apart from
MED12, all of the components identiﬁed belong to the active
form of Mediator. It is of note, however, that MED12 directly
interacts with mammalian β-catenin and activates target genes,
thus indicating that MED12 also has an alternative activating role
[48]. Interestingly, β-catenin is activated during development of
MLL leukaemic stem cells [49].
As our identiﬁcations indicate that AF4 interacts with Pol
II and the Mediator complex, we may speculate that AF4
bindinginducesastructuralchangeinMediatortherebyactivating
stalled Pol II to transition to a positively elongating state and
enabling effective transcription to take place. Therefore the AF4–
Mediator complex interaction might be crucial for activation
of speciﬁc gene expression. In this context, it is of note
that Yokoyama et al. [16] demonstrate that the AEP complex
(AF4, AF5q31, ENL and P-TEFb) co-localizes with wild-type
MLL on speciﬁc target promoters, thereby indicating that this
complex plays a role in physiological as well as in oncogenic
MLL-dependent transcriptional pathways. However, they also
showed that recruitment of AEP to MLL-target loci was not
constitutive, because some MLL-occupied loci (e.g. HOXA7)
did not contain AEP. Therefore these authors hypothesized that
the MLL complex probably requires other, as yet unidentiﬁed,
factors or signals for speciﬁc recruitment of AEP, and concluded
that AEP recruitment, a downstream event in physiological
MLL-dependent transcriptional pathways, is regulated in a
context-dependent manner. This hypothesis suggested that the
results of the present study may be integrated into the Yokoyama
et al. [16] model. Speciﬁcally, we suggest that the Mediator
complex, depending on its subunit composition, plays a crucial
role in the recruitment of the AEP complex on speciﬁc MLL-
target promoters. Indeed, the wild-type MLL complex may
initiate the activation pathway by binding the regulatory region
of target genes. It would then recruit some speciﬁc Mediator
components, in a context-dependent manner. For example, MLL
could recruit the head subunit MED17/TRAP80, a known direct
interactor of ASH2L [ash2 (absent,small, or homeotic)-like] that,
together with RBBP4 (retinoblastoma binding protein 4), an AF4
partner (Supplementary Figure S1), forms the MLL complex
[50,51]. Alternatively, some Mediator components may recruit
MLL directly to the target chromatin. Indeed, PPARBP/MED1
directlyinteractswithvariousligandsofnuclearreceptors(thyroid
hormone receptor, vitamin D receptor, peroxisome proliferator-
activatedreceptor-γ,hepatocytenuclearfactor4α,glucocorticoid
receptor and oestrogen receptor), as well as with non-receptor
type factors such as GATA1 (GATA-binding protein 1). After
these initial recruitments, assembly of the pre-initiation complex,
which entails the various general transcription factors and
Pol II, and transcription initiation then ensue, together with
the concomitant recruitment of other ad hoc components of the
Mediator complex. After Pol II clears the promoter, the process
can proceed directly to the elongation phase thanks to the
Mediator-dependent speciﬁc recruitment of AF4 and the other
components of the AEP complex described by Yokoyama et al.
[16].
Lastly, we found that YWHAQ and YWHAE, two members
of the 14-3-3 protein family, interact with AF4. 14-3-3s are
ubiquitousproteins,usuallycytosolic,thatexertanextraordinarily
wide-ranging inﬂuence on cellular functions, including cell-
cycle control and apoptosis. They operate by binding to
speciﬁc phosphorylated sites on such diverse target proteins as
oncogene products, tumour suppressor proteins, and regulators of
cell survival, proliferation and growth [52]. 14-3-3s are often
associated with dynamic nucleo-cytoplasmic shuttling. Upon
phosphorylation, many nuclear proteins, including transcription
factors, bind to 14-3-3s, which control their rate of nuclear
import/export thereby modulating transcriptional processes [52].
We suggest that 14-3-3s bind phosphorylated AF4 and contribute
to the regulation of its movement into and out of the nucleus.
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In the cytosol, AF4 undergoes rapid proteasomal degradation
via its well-known interaction with SIAH-1a and SIAH-2
ubiquitin ligases [10,11]. This mechanism could closely control
AF4 turnover and, consequently, AF4-dependent transcriptional
elongation. The phosphorylation sites that we have identiﬁed in
AF4 might play a key role in the putative 14-3-3-mediated AF4
regulation/degradation pathway.
The characterization of AF4-interacting proteins reported in
the present paper supports the growing body of evidence that
AF4 is a crucial activator in a multimeric complex that promotes
transcription in human cells, and that this multiprotein complex
is functionally and structurally regulated (i.e. via the availability
of components, phosphorylation, proteosome-mediated degrada-
tion, cellular localization and conformational shifts). Indeed, the
resultsofthepresentstudygreatlyincreasethenumberofputative
components participating in the multiprotein complex formed by
AF4,aswellasbyotherMLLfusionpartners(ENLELL,AF5q31,
AF9 etc.). The information reported in the present paper is
useful for future studies aimed at unravelling the AF4-dependent
molecularmechanisms,therebygivinginsightsintothemolecular
basis of AF4-mediated leukaemia and eventually leading to novel
therapeutictargets.WepreviouslyreportedthatevenwhenMLL–
AF4 chimaeras lack part of the AF4 transactivation domain, they
continuetogiverisetoacutelymphoblasticleukaemia[53].Given
results from previousstudies [16,40]and the results of the present
study, it is now clear also that this altered MLL–AF4 chimaera,
irrespective of the transactivation domain, is able to recruit all of
the protein components that are necessary for the transcription
of genes that enhance and sustain cell transformation.
Note added in press
While this article was being processed, a paper appeared [54] that
contains some results that overlap our ﬁndings.
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Figure S1 Mascot search results
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Table S1 Identiﬁcation of AF4-1-interacting proteins by nano-LC-ESI-MS/MS
Gene symbol Identiﬁed peptide sequence Precursor mass (m/z) Charge state (z) Mass errors (p.p.m.) Single peptide Mascot score Sequence coverage
Transcription regulatory protein
PPARBP SLGMNASVTIEGTSAVYK 922.54 2+ 16 77 3%
GNNQADTVDFSIISVAGK 918.55 2+ 16 71
MED12 IEGTLGVLYDQPR 730.89 2+ 06 7 2 %
LNLVGGMFDTVQR 733.41 2+ 47 68
CRSP2 FLGSVIMR 469.87 2+ 23 41 8%
AGTSSQTMPTNMPPPR 852.90 2+ 11 41
SLLDCTFR 506.44 2+ 37 45
ENIQDLVFR 567.50 2+ 35 49
DGAYSLFDNSK 608.86 2+ 31 43
LELFPDQATQLK 701.91 2+ 42 47
QGECTIFAAVR 626.36 2+ 39 47
LVEGFYPAPGLK 645.95 2+ 39 48
LEILVEDKETGDGR 671.45 3+ 27 61
TFLNMFVDSNQDAR 837.45 2+ 17 94
CRSP3 EVGNALLNVVLK 635.07 2+ 18 47 9%
NALADFLPVMK 617.91 2+ 12 43
FLELLPVSK 523.41 2+ 17 43
LITALGSSEVQPQFTR 874.03 2+ 13 46
LFDLLYPEK 569.48 2+ 29 54
NACLLPAYFAVTEIR 869.48 2+ 28 54
SSVALAPALVETYSR 782.50 2+ 10 55
EVGNALLNVVLK 635.07 2+ 29 61
TVLSAESEELNR 674.33 2+ 14 71
THRAP4 QLAGPLFSENTLQFYNER 1064.10 2+ 15 43 4%
GSVLQFMPFTTVSELVK 950.20 2+ 10 40
CRSP6 AAATIDSLASR 538.30 2+ 37 57 6%
VLITSQGYEQICK 769.95 2+ 35 76
CRSP7 LLQAIDPQSNIR 684.38 2+ 14 45 6%
AGLSPAEPLLSR 605.89 2+ 75 4
NEIIQSYLSR 611.82 2+ 85 1
RBBP4 TPSSDVLVFDYTK 736.38 2+ 27 104 4%
RUVBL2 GLGLDDALEPR 578.75 2+ 80 50 3%
EAF1 GDEVTITLPHIPGSTPPMTVFK 785.06 3+ 17 70 9%
MED4 LLSALEDLEVLSR 729.44 2+ 20 73 17%
EAEQILATAVYQAK 767.75 2+ 26 76
LGGGLGVAGGNSTR 608.33 2+ 26 62
CRSP8 GYNENVYTEDGK 694.85 2+ 12 64 33%
AFIAHFQDNLHSVNR 590.37 2+ 18 51
AQPTTLVLPPQYVDDVISR 704.66 3+ 84 8
SNYQVFQK 507.26 2+ 94 7
MED7 EYTDENIQEGLAPKPPPPIK 514.33 3+ 58 44 9%
MED6 VDALLLDLR 514.39 2+ 15 47 17%
QRVDALLLDLR 647.92 2+ 74 7
VLTAVHGIQSAFDEAMSYCR 757.73 3+ 12 48
MED8 NQVIIPLVLSPDR 732.46 2+ 34 65 23%
VPVFSHEVVPDHLR 544.35 3+ 10 40
QTFNPTDTNALVAAVAFGK 983.07 2+ 16 115
NQVIIPLVLSPDRDEDLMR 741.72 3+ 13 44
TRFP SVQQTVELLTR 637.38 2+ 31 53 10%
YQYCDFLVK 618.20 2+ 16 56
MED21 IQSALADIAQSQLK 743.44 2+ 40 55 10%
ELL TSLLLLR 405.29 2+ 22 49 5%
EPVQALPSSASR 924.12 2+ 04 1
PCQAP TFVPAMTAIHGPPITAPVVCTR 784.68 2+ 18 46 12%
QSIPSVLQGEVAR 692.45 2+ 14 58
SLLDILTDPSK 601.51 3+ 19 61
TCEA1 NIPMTLELLQSTR 766.43 2+ 39 63 5%
DNA-directed RNA polymerase
POLR2A TVITPDPNLSIDQVGVPR 961.01 2+ 16 61 1%
POLR2B AGVSQVLNR 472.27 2+ 04 5 4 %
NLTYSAPLYVDITK 799.43 2+ 64 7
TVTLPENEDELESTNR 923.89 2+ 18 60
POLR2C ITELTDENVK 581.27 2+ 10 55 12%
LGLIPLISDDIVDK 755.92 2+ 12 42
FIIENTDLAVANSIR 838.42 2+ 16 82
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Table S1 Continued
Gene symbol Identiﬁed peptide sequence Precursor mass (m/z) Charge state (z) Mass errors (p.p.m.) Single peptide Mascot score Sequence coverage
DNA-binding protein
MCM3 GSSGVGLTAAVTTDQETGER 968.44 2+ 20 100 3%
RUVBL1 TALALAIAQELGSK 693.38 2+ 14 70 3%
RNA-binding protein
NCL SISLYYTGEK 580.96 2+ 28 47 8%
GFGFVDFNSEEDAK 781.40 2+ 17 50
NDLAVVDVR 500.84 2+ 13 55
GLSEDTTEETLKESFDGSVR 734.06 3+ 13 62
PRPF31 IYEYVESR 529.66 2+ 18 47 14%
LGLTEIR 401.20 2+ 11 47
IMGVAGGLTNLSK 638.87 2+ 39 64
MPACNIMLLGAQR 754.01 2+ 19 40
SSGTASSVAFTPLQGLEIVNPQAAEK 868.14 3+ 27 41
SNRPD2 GDSVIVVLR 479.27 2+ 16 47 17%
Protein serine/threonine kinase protein
CDK9 LADFGLAR 431.75 2+ 11 42 43%
LLVLDPAQR 512.84 2+ 18 42
DPYALDLIDK 581.80 2+ 85 4
IGQGTFGEVFK 591.81 2+ 06 3
NPATTNQTEFER 704.33 2+ 06 5
HENVVNLIEICR 784.45 2+ 87 2
AYVRDPYALDLIDK 551.32 2+ 18 45
NPATTNQTEFERVF 827.70 2+ 16 59
QYDSVECPFCDEVSK 931.84 2+ 13 63
VLMENEKEGFPITALR 621.67 3+ 16 42
VVTLWYRPPELLLGER 647.93 3+ 15 45
Serine/threonine phosphatase protein
PPP2R1A IGPILDNSTLQSEVKPILEK 732.21 3+ 26 55 6%
VLAMSGDPNYLHR 496.78 3+ 17 47
Translation regulator protein
EEF1B2 SPAGLQVLNDYLADK 802.45 2+ 43 88 7%
Auxiliary transport protein
GDI2 LYSESLAR 469.70 2+ 16 42 4%
FVSISDLLVPK 609.30 2+ 18 48
TDDYLDQPCYETINR 952.30 2+ 14 49
Receptor signalling complex scaffold protein
YWHAE EAAENSLVAYK 597.84 2+ 12 41 29%
DSTLIMQLLR 603.33 2+ 05 1
EALQDVEDENQ 645.21 2+ 10 56
VAGMDVELTVEER 732.36 2+ 69 7
LICCDILDVLDK 738.93 2+ 14 74
AASDIAMTELPPTHPIR 612.70 2+ 15 76
YWHAQ DSTLIMQLLR 595.32 2+ 13 49 38%
YLAEVACGDDR 634.73 2+ 18 59
YLIANATNPESK 660.83 2+ 13 65
SICTTVLELLDK/AVTEQGAELSNEER 696.45 2+ 10 73
QTIDNSQGAYQEAFDISK 766.99 2+ 16 97
QTIDNSQGAYQEAFDISKK 999.51 2+ 10 81
SPIN VSALEVLPDR 549.81 2+ 18 57 4%
AP3S1 SEAGLAGAPAR 500.27 2+ 39 55 6%
Signal transduction
CCNT1 QLENMEANVK 587.87 2+ 17 48 38%
QQAANLLQDMGQR 736.55 2+ 27 71
TYSLSSSFSSSSSTR 792.37 2+ 12 88
GPSEETGGAVFDHPAK 800.02 2+ 11 78
MPIEGSENPERPFLEK 940.48 2+ 26 40
SQYAYAAQNLLSHHDSHSSVILK 857.12 2+ 27 73
SGNTDKPRPPPLPSEPPPPLPPLPK 876.24 3+ 18 50
TSENLALTGVDHSLPQDGSNAFISQK 910.82 3+ 16 60
S100A8 LLETECPQYIR 711.37 2+ 14 53 25%
S100A9 NIETIINTFHQYSVK 904.09 2+ 12 54 21%
KDLQNFLK 503.28 2+ 19 42
Transmembrane receptor protein tyrosine kinase protein
FGFR2 NVLVTENNVMKIADFGLAR 702.03 3+ 19 40 3%
Lipid kinase protein
c   The Authors Journal compilation c   2011 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.The human AF4 protein network
Table S1 Continued
Gene symbol Identiﬁed peptide sequence Precursor mass (m/z) Charge state (z) Mass errors (p.p.m.) Single peptide Mascot score Sequence coverage
PIP5K2B FGIDDQDYQNSVTR 829.33 2+ 14 88 8%
FFGPGEFDPSVDVYAMK 961.47 2+ 16 42
PIP5K2C FGIDDQDYLVSLTR 821.49 2+ 17 96 11%
VSVDNEDSYMLVMR 837.40 2+ 24 94
DRFGIDDQDYLVSLTR 638.40 3+ 13 57
Heterotrimeric G-protein GTPase protein
GNB4 LIIWDSYTTNK 677.32 2+ 44 43 7%
Guanyl-nucleotide-exchange factor protein
ARHGEF4 YPLQLAELLK 594.31 2+ 15 41 2%
Enzyme: dehydrogenase
GAPDH VPTANVSVVDLTCR 765.90 2+ 0 68 13%
LISWYDNEFGYSNR 882.35 2+ 10 64
Enzyme: synthase
PTS VYETDNNIVVYKGE 821.83 2+ 73 47 10%
Unknown
SMAD9 VETPVLPPVLVPR 708.45 2+ 21 52 6%
FCLGLLSNVNR 646.84 2+ 75 6
LSM14A EFADFEYR 538.75 2+ 18 49 12%
SFFDNISCDDNR 745.35 2+ 67 1
DFDFESANAQFNK 766.86 2+ 32 70
YEGILYTIDTENSTVALAK 1051.06 2+ 19 83
DRG1 IQLLDLPGIIEGAK 740.41 2+ 27 41 4%
HCCA2 LVTDEDVFPTK 632.34 2+ 14 55 10%
EFPSSFESLVR 649.36 2+ 23 59
C20orf11 LIMNYLVTEGFK 714.36 2+ 17 13 6%
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Table S2 Analysis of control lane by nano-LC-ESI-MS/MS
Gene symbol Identiﬁed Peptide sequence Precursor mass (m/z) Charge state (z) Mass errors (p.p.m.) Single peptide Mascot acore Sequence coverage
FLNA VANPSGNLTETYVQDR 767,51 2+ 2+ 2+ 07 4 4 %
GAGTGGLGLAVEGPSEAK 785,93 2+ 31 42
ANLPQSFQVDTSK 882,43 2+ 62 41
JAK1 LSDPGIPITVLSR 684,39 2+ 14 41 3%
SDVLTTPWKFK 661,34 2+ 15 48
KIF11 LTDNGTEFSVK 605,83 2+ 59 47 9%
TTAATLMNAYSSR 701,88 2+ 64 55
ETTIDGEELVK 617,32 2+ 16 47
EEYITSALESTEEK 814,92 2+ 48 94
FCALEEK 448,73 2+ 33 48
CENIQKPLSSVQENIQQK 715,02 3+ 18 60
SKVEETTEHLVTK 500,96 3+ 53 64
PRMT5 SDLLLSGR 430,76 2+ 33 49 10%
KGFPVLSK 438,30 2+ 68 42
YSQYQQAIYK 646,33 2+ 15 74
DTNVQVLMVLGAGR 744,94 2+ 60 77
GPLVNASLR 463 ,81 2+ 10 40
DPEAQFEMPYVVR 798,80 2+ 37 62
HSPA1A NQVALNPQNTVFDAKR 605,63 3+ 44 40 9%
ATAGDTHLGGEDFDNR 838,37 2+ 05 6
ARFEELCSDLFR 771,89 2+ 25 57
GGSGSGPTIEEVD 602,77 2+ 04 8
PPM1B YGLSSMQGWR 600,77 2+ 85 0 8 %
HIYFINCGDSR 691,34 2+ 28 55
DNMSIVLVCFSNAPK 855,96 2+ 52 80
STK38 LGLEDFESLK 575,56 2+ 78 58 11%
DIKPDNLLLDSK 457,60 3+ 22 53
LSDFGLCTGLK 605,79 2+ 33 53
IGAPGVEEIK 506,74 2+ 88 65
RFEGLTAR 475,22 2+ 94 42
PFKFB3 STIQTAEALR 545,17 2+ 73 37 6%
YPTGESYQDLVQR 778,04 2+ 43 61
VFNVGEYR 492,24 2+ 20 44
TUBB ISVYYNEATGGK 651,2 2+ 84 59 12%
AILVDLEPGTMDSVR 816,37 2+ 64 55
IMNTFSVVPSPK 668,28 2+ 104 78
LAVNMVPFPR 580,27 2+ 86 51
TUBB2C AVLVDLEPGTMDSVR 809,37 2+ 49 41 8%
FPGQLNADLR 565,75 2+ 53 44
LAVNMVPFPR 580,27 2+ 86 51
HNRPH1 GLPWSCSADEVQR 752,78 2+ 86 63 12%
SNNVEMDWVLK 675,78 2+ 59 58
YGDGGSTFQSTTGHCVHMR 705,24 3+ 85 41
VHIEIGPDGR 546,80 2+ 94 2
PFKFB3 EGGQIAVFDATNTTR 790,29 2+ 126 58 8%
YPTGESYQDLVQR 778,26 2+ 140 109
LEPVIMELER 622,74 2+ 144 41
TUBA1A EIIDLVLDR 543,29 2+ 46 41 5%
DVNAAIATIK 508,23 2+ 128 58
ATP5A1 VVDALGNAIDGK 586,28 2+ 68 52 4%
AVDSLVPIGR 513,79 2+ 19 40
TRIM21 NFLVEEEQR 582,33 2+ 68 37 4%
DLDITSPELR 579,79 2+ 25 62
MYC STTTGHLIYK 560,77 2+ 62 40 5%
IGGIGTVPVGR 513,30 2+ 19 64
ACTB AVFPSIVGRPR 559,91 2+ 91 49 16%
DSYVGDEAQSKR 977,51 2+ 22 61
GYSFTTTAER 566,77 2+ 85 0
SYELPDGQVITIGNER 895,93 2+ 22 52
EITALAPSTMK 589,27 2+ 67 44
WDR77 ETPPPLVPPAAR 622,8 2+ 88 87 8%
SDGALLLGASSLSGR 702,37 2+ 14 87
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Table S3 In silico analysis of AF4 interactors by HPRD (http://www.hprd.org)
Gene name Interactors Type of interaction
Transcription regulatory protein
PPARBP 14-3-3 Eta (*) Direct
Androgen receptor Direct
CRSP2 (*) Direct
Estrogen receptor alpha Direct
Estrogen receptor beta Direct
GATA binding protein 1 Direct
GATA binding protein 3 Direct
Hepatocyte nuclear factor 4 alpha Direct
Nuclear receptor subfamily 4,group A, member 1 Direct
Peroxisome proliferator activated receptor gamma Direct
Peroxisome proliferator activated receptor, alpha Direct
RAR related orphan receptor A Direct
Retinoid X receptor, alpha Direct
TRAP230 (*) Direct




PPAR gamma coactivator 1 Direct
Retinoic acid receptor alpha Direct
Mediator of RNA polymerase II transcription subunit 8 (*) Direct
Thyroid hormone receptor alpha Direct
Thyroid hormone receptor, beta Direct
GATA binding protein 4 Direct
GATA binding protein 6 Direct





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7
Thyroid hormone receptor associated protein 1 Complex
TRAP230 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
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Table S3 Continued
Gene name Interactors Type of interaction
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
CRSP2 (*)
RNA polymerase II transcriptional regulation mediator (*)




Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28
Thyroid hormone receptor associated protein 1
TRAP230 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)





Mediator complex subunit 28 Complex
Thyroid hormone receptor associated protein 1
TRAP230 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)









Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Thyroid hormone receptor associated protein 6
RING3 Complex
Cyclin dependent kinase 8
RNA polymerase IIA 220 kd subunit
CRSP2 (*) Complex
Thyroid hormone receptor associated protein 1
TRAP230 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
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Table S3 Continued
Gene name Interactors Type of interaction
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Peroxisome proliferator activated receptor, alpha Complex
CREBBP
ATP binding cassette, subfamily C, member 9
SRC1
E1A binding protein p300
Tryptophan rich basic protein
PPAR gamma coactivator 1
Nuclear receptor coactivator 6
TRAP100 (*)
Nuclear receptor coactivator 6 interacting protein
TRAP100 (*) Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue Complex
Cyclin dependent kinase 8





Transcriptional coactivator CRSP130 (*)
Transcriptional coactivator CRSP70 (*)
Transcriptional coactivator CRSP34 (*)
CRSP9 (*)
MED12 TRAP230 (*) Direct
Cyclin dependent kinase 8 Direct
TRAP220 (*) Direct
Transcriptional coactivator CRSP70 (*) Direct
Lysosomal trafﬁcking regulator Direct
SOX9 Direct
Mediator of RNA polymerase II transcription subunit 8 (*) Direct





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1
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Table S3 Continued
Gene name Interactors Type of interaction
Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7
Mediator complex subunit 28 Complex
Thyroid hormone receptor associated protein 1
TRAP220 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Thyroid hormone receptor associated protein 1 Complex
TRAP220 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28
Thyroid hormone receptor associated protein 1
TRAP220 (*)
CRSP2 (*)
Transcriptional coactivator CRSP130 (*)














Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator
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Table S3 Continued
Gene name Interactors Type of interaction
Thyroid hormone receptor associated protein 6
CRSP2 (*) Complex
Thyroid hormone receptor associated protein 1 Complex
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
CRSP2 Glucocorticoid receptor Direct
Androgen receptor Direct








Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7
Thyroid hormone receptor associated protein 1 Complex
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
RNA polymerase II transcriptional regulation mediator (*)
Cyclin dependent kinase 8
TRAP220 (*)
TRAP100 (*)
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Table S3 Continued
Gene name Interactors Type of interaction
SRB7
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28
Thyroid hormone receptor associated protein 1
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)





Mediator complex subunit 28 Complex
Thyroid hormone receptor associated protein 1
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Thyroid hormone receptor associated protein 1 Complex
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
RNA polymerase II transcriptional regulation mediator (*) Complex
Cyclin dependent kinase 8
Cyclin C
SRB7
Mediator complex subunit 28 Complex
TRAP95
Vitamin D receptor interacting protein (*)




Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
TRAP95
TRAP 80 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
Trf proximal protein




Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
RNA polymerase II transcriptional regulation mediator (*)
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Table S3 Continued




Transcriptional coactivator CRSP130 (*)





Transcriptional coactivator CRSP130 (*)
Transcriptional coactivator CRSP70 (*)
Transcriptional coactivator CRSP34 (*)
CRSP9 (*)
CRSP3 CCAAT/Enhancer binding protein, beta Direct
E74 like factor 3 Direct
Nuclear receptor coactivator 6 Direct
Thyroid hormone receptor associated protein 1 Direct
Pumilio2 Direct
WD and tetratricopeptide repeats 1 Direct






Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
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Table S3 Continued
Gene name Interactors Type of interaction
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28









Mediator complex subunit 28 Complex






Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)




Thyroid hormone receptor associated protein 1
TRAP230 (*)
TRAP220 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
Vitamin D receptor interacting protein (*)









Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)











Transcriptional coactivator CRSP70 (*)
Transcriptional coactivator CRSP34 (*)
CRSP9 (*)
THRAP4 Estrogen receptor alpha Direct
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Table S3 Continued
Gene name Interactors Type of interaction
Peroxisome proliferator activated receptor gamma Direct
Peroxisome proliferator activated receptor, alpha Direct






Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
CRSP2 (*)
RNA polymerase II transcriptional regulation mediator (*)




Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28




Transcriptional coactivator CRSP130 (*)
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Table S3 Continued
Gene name Interactors Type of interaction




Mediator complex subunit 28 Complex




Transcriptional coactivator CRSP130 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Peroxisome proliferator activated receptor, alpha Complex
CREBBP
ATP binding cassette, subfamily C, member 9
SRC1
E1A binding protein p300
Tryptophan rich basic protein
TRAP220 (*)
PPAR gamma coactivator 1
Nuclear receptor coactivator 6
Nuclear receptor coactivator 6 interacting protein
Mediator of RNA polymerase II transcription subunit 25 homologue Complex
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
TRAP95
TRAP 80 (*)
Transcriptional coactivator CRSP130 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
PC2
CRSP6 Mediator of RNA polymerase II transcription subunit 19 Direct
Surfeit 5 Direct
Thyroid hormone receptor associated protein 6 Direct
p53 Direct
Mediator of RNA polymerase II transcription subunit 8 (*) Direct
Ubiquitin speciﬁc protease 49 Direct
BRCA1 Complex
BRCA1 associated ring domain 1
SMARCA4





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
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Table S3 Continued
Gene name Interactors Type of interaction
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1




Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
Mediator complex subunit 28




Transcriptional coactivator CRSP130 (*)





Mediator complex subunit 28 Complex




Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Mediator complex subunit 28 Complex
Surfeit 5
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Table S3 Continued








Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Thyroid hormone receptor associated protein 6
Mediator of RNA polymerase II transcription subunit 8 (*) Complex
Intersex like
TRAP100 (*) Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
Transcriptional coactivator CRSP70 (*)





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
TRAP95
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
Trf proximal protein







Transcriptional coactivator CRSP130 (*)
Transcriptional coactivator CRSP70 (*)
Transcriptional coactivator CRSP34 (*)
CRSP9 (*)
CRSP7 Cyclin dependent kinase 8 Direct
TRAP230 (*) Direct
Mediator of RNA polymerase II transcription subunit 8 (*) Direct






Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)
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Table S3 Continued
Gene name Interactors Type of interaction
Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7
Mediator complex subunit 28 Complex




Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Mediator complex subunit 28 Complex
MED9
Intersex like
Mediator of RNA polymerase II transcription subunit 19
TRAP100 (*) Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)





Transcriptional coactivator CRSP130 (*)






Transcriptional coactivator CRSP130 (*)




Chromatin assembly factor 1 subunit B Direct
Histone H3 K9 methyltransferase 1 Direct
Histone deacetylase 1 Direct
Inhibitor of growth 1 Direct
Retinoblastoma 1 Direct
Retinoblastoma binding protein 7 Direct
Transcription factor Sp1 Direct
Transcription factor Sp3 Direct
Sin3 associated polypeptide ,30KD Direct
Metastasis associated protein MTA1 Direct
Methyl CpG binding domain protein 2 Direct
Methyl CpG binding domain protein 3 Direct
Histone deacetylase 2 Direct
Breast cancer metastasis suppressor 1 Direct
Retinol binding protein 1 Direct
Metastasis associated protein MTA2 Direct
Histone deacetylase 3 Direct
SIN3A Direct
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Table S3 Continued
Gene name Interactors Type of interaction
Hypothetical protein MGC4677 Direct
AE binding protein 2 Direct
Breast cancer metastasis suppressor 1 like Direct
Histone deacetylase 4 Direct
H2A histone family member Q Direct
Histone 2 H3c Direct
SHARP Direct
CD8 Antigen, alpha polypeptide Complex
Histone deacetylase 1
Eukaryotic translation initiation factor 3, subunit 10
Retinoblastoma binding protein 7
Chromodomain helicase DNA binding protein 4
Sin3 associated polypeptide ,30KD
Methyl CpG binding domain protein 2
Methyl CpG binding domain protein 3
Histone deacetylase 2





AE binding protein 2
Histone deacetylase 1 Complex
Retinoblastoma binding protein 7
Metastasis associated protein MTA1
Histone deacetylase 2
Metastasis associated protein MTA2
Methyl-CpG binding domain protein 3-like 1
Histone deacetylase 1 Complex
Inhibitor of growth 1
Sin3 associated polypeptide ,30KD
Retinol binding protein 1
SIN3A
Histone deacetylase 1 Complex
Retinoblastoma binding protein 7
Sin3 associated polypeptide, 18 kd
Sin3 associated polypeptide ,30KD
Histone deacetylase 2
Histone deacetylase 1 Complex
Retinoblastoma binding protein 7
Methyl CpG binding domain protein 3
Histone deacetylase 2
Metastasis associated protein MTA2
Chromodomain helicase DNA binding protein 3
Metastasis associated protein MTA3
Polycomb protein SUZ12 Complex
EED
Chromatin assembly factor 1 subunit B Complex
Chromatin assembly factor 1 subunit A




Nuclear receptor corepressor 2
Histone deacetylase 3
Nuclear receptor corepressor 1
mSDS3 Complex
Histone deacetylase 1
Retinoblastoma binding protein 7







Heat shock 70 KD protein 1A
HSP90A
Host cell factor C1
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Table S3 Continued
Gene name Interactors Type of interaction
Histone deacetylase 1
Retinoblastoma binding protein 7
Sin3 associated polypeptide ,30KD
ASH2 like
Histone deacetylase 2
Heat shock 70kDa protein 8
SIN3A
SIN3B
WD repeat domain 5
RUVBL2 Activating transcription factor 2 Direct
BAF53 Direct
Proliferating cell nuclear antigen Direct
RuvB like 1 (*) Direct
RuvB like 2 (*) Direct
Catenin beta Direct
Exosome component 10 Direct
Bcl 3 Direct
Histone deacetylase 1 Direct
Histone deacetylase 4 Direct
Mortality factor 4 like protein 1 Complex
Sarcoma antigen NY-SAR-91
Inhibitor of growth family member 3
EPC1
Enhancer of polycomb homologue 2
HIV-1 Tat interacting protein, 60kDa
Actin beta
HIV-1 Tat interacting protein, 60kDa
Glioma ampliﬁed sequence 41
Bromodomain containing 8
350/400kDa PCAF associated factor
Actin-like 6A
DMAP1
RuvB like 1 (*)
E1A binding protein p400
HIV-1 Tat interacting protein, 60kDa Complex
Actin beta
Mortality factor 4 like 2
HIV-1 Tat interacting protein, 60kDa
Inhibitor of growth family member 3
Glioma ampliﬁed sequence 41
Bromodomain containing 8
350/400kDa PCAF associated factor
Actin-like 6A
DMAP1
E1A binding protein p400
Mortality factor 4 like protein 1
Sarcoma antigen NY-SAR-91
EPC1
Heat shock 70 KD protein 1A
Ribosomal L1 domain containing 1
C20orf20 protein
RuvB like 1 (*)
HIV-1 Tat interacting protein, 60kDa Complex
350/400kDa PCAF associated factor
Bromodomain containing 8
E1A binding protein p400
EPC1
Enhancer of polycomb homologue 2
HIV-1 Tat interacting protein, 60kDa
Inhibitor of growth family member 3
Mortality factor 4 like protein 1




RuvB like 1 (*)
Glioma ampliﬁed sequence 41
Actin-like 6A
TCFL1
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Table S3 Continued
Gene name Interactors Type of interaction
RNA polymerase II subunit 5-mediating protein Complex
RuvB like 1 (*)
BCR downstream signaling 1
S phase kinase associated protein 2
NHP2 like protein 1 Complex
Nucleolar protein NOP5
Fibrillarin
NHP2 like protein 1
NOP56
RuvB like 1 (*)
RNA
EAF1 Elongation factor, RNA polymerase II, 2 Direct






Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28
Thyroid hormone receptor associated protein 1
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Table S3 Continued




Transcriptional coactivator CRSP130 (*)





Mediator complex subunit 28 Complex




Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
RNA polymerase II transcriptional regulation mediator (*)
SRB7
CRSP9 (*)
Mediator complex subunit 28 Complex
CRSP2 (*)
TRAP95




Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
RNA polymerase II transcriptional regulation mediator (*)
TRAP95
TRAP 80 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
PC2
CRSP8 Mediator of RNA polymerase II transcription subunit 19 Direct
Surfeit 5 Direct
Thyroid hormone receptor associated protein 6 Direct







Transcriptional coactivator CRSP130 (*)
Transcriptional coactivator CRSP70 (*)
CRSP9 (*)
CRSP9 Mediator of RNA polymerase II transcription subunit 8 (*) Direct
MED9 Direct









Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
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Table S3 Continued










Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1




Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28




Transcriptional coactivator CRSP130 (*)




Mediator complex subunit 28 Complex
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Table S3 Continued
Gene name Interactors Type of interaction




Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)







Transcriptional coactivator CRSP130 (*)
Transcriptional coactivator CRSP70 (*)
Transcriptional coactivator CRSP34 (*)
MED 6 ADP ribosyl transferase Direct
Retinoic acid receptor alpha Direct
SMAD1 Direct
SMAD2 Direct
Mediator of RNA polymerase II transcription subunit 8 (*) Direct






Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
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Table S3 Continued
Gene name Interactors Type of interaction
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28




Transcriptional coactivator CRSP130 (*)











Mediator complex subunit 28 Complex




Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
TRAP95
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Transcriptional coactivator CRSP70 (*)
Vitamin D receptor interacting protein (*)
SRB7
CRSP9 (*)










Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19





Thyroid hormone receptor associated protein 6
CRSP2 (*) Complex
Thyroid hormone receptor associated protein 1
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
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Table S3 Continued
Gene name Interactors Type of interaction
Mediator of RNA polymerase II transcription subunit 8 (*)
CRSP2 (*) Complex




Cyclin dependent kinase 8
Cyclin C
TRAP100 (*) Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)





Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator complex subunit 28 Complex
CRSP2 (*)
TRAP95




Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
Vitamin D receptor interacting protein (*)
TRAP95
TRAP 80 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)
Trf proximal protein




Mediator of RNA polymerase II transcription subunit 25 homologue
Cyclin dependent kinase 8
Intersex like Complex
Thyroid hormone receptor alpha
Mediator of RNA polymerase II transcription subunit 8 (*)
MED8 CRSP9 (*) Direct
Cyclin C Direct
Cyclin dependent kinase 8 Direct
RNA polymerase II transcriptional regulation mediator (*) Direct
Surfeit 5 Direct
TRAP 80 (*) Direct
TRAP220 (*) Direct
TRAP230 (*) Direct
Transcription elongation factor B, 1 Direct
Transcriptional coactivator CRSP34 (*) Direct
Transcriptional coactivator CRSP70 (*) Direct
Ubiquitin speciﬁc protease 49 Direct
Thyroid hormone receptor associated protein 6 Direct
Mediator of RNA polymerase II transcription subunit 25 homologue Direct
Mediator complex subunit 28 Direct
Mediator of RNA polymerase II transcription, subunit 31 homologue Direct
MED9 Direct
Similar to HSPC296 Direct
Trf proximal protein Direct
Mediator of RNA polymerase II transcription subunit 19 Direct
Ngg1 interacting factor 3 like 1 binding protein 1 Direct





Transcriptional coactivator CRSP130 (*)
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Table S3 Continued
Gene name Interactors Type of interaction
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein (*)
Mediator of RNA polymerase II transcription subunit 19





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Trf proximal protein
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28










Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19





Thyroid hormone receptor associated protein 6
CRSP2 (*) Complex
Thyroid hormone receptor associated protein 1
TRAP230 (*)
TRAP220 (*)
Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
Mediator of RNA polymerase II transcription subunit 25 homologue
Acyl-coenzyme A dehydrogenase 8
Actin related protein 2/3 complex subunit 2, 34kDa
RNA polymerase II transcriptional regulation mediator (*)
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Table S3 Continued
Gene name Interactors Type of interaction
Transcription elongation factor B, 2 Complex
Transcription elongation factor B, 1
Cullin 2
Ring-box 1
TRAP 80 (*) Complex
Intersex like
RNA polymerase II transcriptional regulation mediator (*) Complex
Intersex like
Thyroid hormone receptor alpha







Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Transcriptional coactivator CRSP70 (*)
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)




Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
SRB7




Transcriptional coactivator CRSP130 (*)
Positive cofactor 2 glutamine
TRAP100 (*)
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription subunit 8 (*)
Thyroid hormone receptor associated protein 6
SRB7
CRSP9 (*)
Mediator complex subunit 28
Cyclin C Complex
Cyclin dependent kinase 8
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80 (*)
Mediator complex subunit 28




Transcriptional coactivator CRSP130 (*)
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Table S3 Continued
Gene name Interactors Type of interaction















Cyclin dependent kinase 8
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator (*)




Thyroid hormone receptor associated protein 6
Mediator complex subunit 28 Complex
CRSP2 (*)
TRAP95
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
MED18
SRB7
Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2 (*)
Vitamin D receptor interacting protein (*)
RNA polymerase II transcriptional regulation mediator (*)
TRAP95
TRAP 80 (*)
Transcriptional coactivator CRSP130 (*)
TRAP100 (*)




Basic transcription factor 3 Direct
Cyclin dependent kinase 8 Direct
RNA polymerase IIA 220 kd subunit Direct
TRK fused gene Direct
Transcription elongation factor B, 3 Direct
Cyclin dependent kinase 9 Direct






Cyclin dependent kinase 8
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1





Positive cofactor 2 glutamine
TRAP100
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80
Vitamin D receptor interacting protein
RNA polymerase II transcriptional regulation mediator
Mediator of RNA polymerase II transcription subunit 8
Trf proximal protein
Thyroid hormone receptor associated protein 6
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Table S3 Continued
Gene name Interactors Type of interaction
CRSP9
Mediator complex subunit 28
Cyclin C Complex
CRSP2
RNA polymerase II transcriptional regulation mediator




Cyclin dependent kinase 8
Vitamin D receptor interacting protein
RNA polymerase II transcriptional regulation mediator
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue
TRAP 80
Mediator complex subunit 28









Mediator complex subunit 28 Complex







Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80
Transcriptional coactivator CRSP70
Vitamin D receptor interacting protein







Positive cofactor 2 glutamine
TRAP100
Transcriptional coactivator CRSP70
Cyclin dependent kinase 8
Cell division cycle 2 like 1
Vitamin D receptor interacting protein
Mediator of RNA polymerase II transcription subunit 19
RNA polymerase II transcriptional regulation mediator





Mediator complex subunit 28
THRAP2
Thyroid hormone receptor associated protein 1





Thyroid hormone receptor associated protein 6
Mediator complex subunit 28
Similar to HSPC296
Mediator of RNA polymerase II transcription, subunit 31 homologue
CRSP2 Complex
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Table S3 Continued
Gene name Interactors Type of interaction
RNA polymerase II transcriptional regulation mediator
Cyclin dependent kinase 8
Cyclin C
RNA polymerase II transcriptional regulation mediator Complex
Cyclin dependent kinase 8
Cyclin C
TRAP100 Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80
Transcriptional coactivator CRSP70




Positive cofactor 2 glutamine
Mediator complex subunit 28 Complex
CRSP2
TRAP95
Vitamin D receptor interacting protein
RNA polymerase II transcriptional regulation mediator
MED18
Trf proximal protein
Mediator of RNA polymerase II transcription, subunit 31 homologue Complex
CRSP2
Vitamin D receptor interacting protein






Thyroid hormone receptor associated protein 6
PC2
TRAP100 Complex
Mediator of RNA polymerase II transcription subunit 25 homologue
TRAP 80
Transcriptional coactivator CRSP70




Positive cofactor 2 glutamine
ELL3 None
TCEA1 Transcription factor IIE, alpha subunit Direct
CTD phosphatase, subunit 1 Direct
CBF1 interacting corepressor Direct
RNA polymerase IIA 220 kd subunit Direct
EAF2 Direct
Elongin A binding protein 1 Direct
Hypothetical protein FLJ10006 Direct
DNA-directed RNA polymerase protein
POLR2A ABL Direct




BRCA1 associated ring domain 1 Direct
CREBBP Direct
CTD phosphatase, subunit 1 Direct
Caspase 10 Direct
Cleavage and polyadenylation speciﬁcity factor 1 Direct
Cleavage and polyadenylation speciﬁcity factor 2 Direct
Cleavage and polyadenylation speciﬁcity factor 3 Direct
CstF 50 Direct
Cyclin dependent kinase 8 Direct
EBNA2 coactivator p100 Direct
ERCC6 Direct
FUS Direct
Heterogenous nuclear ribonucleoprotein F Direct
Non pou domain containing octamer binding protein Direct
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Table S3 Continued
Gene name Interactors Type of interaction
Pin1 Direct
Polyglutamine binding protein 1 Direct
Polymerase II, RNA, subunit F Direct
Polymerase II, RNA, subunit L Direct
RENT1 Direct
RNA polymerase II elongation factor ELL Direct
RNA polymerase II subunit 3 Direct
RNA polymerase II subunit D Direct
RNA polymerase II subunit G Direct
RNA polymerase IIA 25 kd subunit Direct
SUPT5H Direct
Scaffold Attachment Factor B Direct
Small CTD phosphatase 1 Direct
Survival of motor neuron 1, telomeric Direct
TATSF1 Direct
Transcription elongation factor A, 1 Direct
Zinc ﬁnger protein 74 Direct
Kallikrein 2 Direct
ERCC5 Direct
Transcription initiation factor IIB Direct
Cyclin K Direct
Cyclin L2 Direct
Peptidyl prolyl isomerase G Direct
TAF10 RNA polymerase II TATA box binding protein TBP-associated factor 30 Kd Direct
XPA binding protein 2 Direct




Chorionic somatomammotropin hormone 2 Direct
Translocation associated membrane protein 2 Direct
Phosphorylated CTD interacting factor 1 Direct
CDC2 related protein kinase 7 Direct
Transcription elongation regulator 1 Direct
Ku antigen, 80kDa Direct
Ccctc binding factor Direct
Cyclin dependent kinase 9 Direct
BRCA1 Complex









Cyclin dependent kinase 8
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
RING3 Complex




Wolf-Hirschhorn syndrome candidate 2
Nucleolin Complex
Cyclin T1
PPAR gamma coactivator 1
Cleavage and polyadenylation speciﬁcity factor 2
Cyclin dependent kinase 9
BRCA1 Complex
BRCA1 associated ring domain 1
Human capping enzyme 1 Complex
mRNA-cap:m7G methyltransferase





DNA excision repair protein ERCC-8
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Table S3 Continued
Gene name Interactors Type of interaction
COP9 signalosome subunit 4
Damage-speciﬁc DNA binding protein 1, 127kDa
G protein pathway suppressor 1
COP9 constitutive photomorphogenic homologue subunit 6
COP9 constitutive photomorphogenic homologue subunit 7A
COP9 constitutive photomorphogenic homologue subunit 8
RNA polymerase II subunit D Complex
RNA polymerase IIA 25 kd subunit
Polymerase II, RNA, subunit F
RNA polymerase II subunit G
RNA polymerase II, polypeptide H
Polymerase 2, RNA, subunit K
Polymerase II, RNA, subunit L
RNA polymerase II subunit J
RNA polymerase II subunit I
BRCA1
RNA polymerase II subunit 2








DNA excision repair protein ERCC-8
Damage-speciﬁc DNA binding protein 1, 127kDa
G protein pathway suppressor 1
COP9 constitutive photomorphogenic homologue subunit 6
COP9 constitutive photomorphogenic homologue subunit 8
Cullin 4A Complex
DNA excision repair protein ERCC-8
Casein kappa
Damage-speciﬁc DNA binding protein 1, 127kDa
COP9 constitutive photomorphogenic homologue subunit 6
COP9 constitutive photomorphogenic homologue subunit 8
Thyroid hormone receptor interactor 15
Ring-box 1
Chorionic somatomammotropin hormone 2 Complex
XPA binding protein 2
POLR2C ATF4 Direct
Activating transcription factor 7 interacting protein Direct
Myogenic factor 4 Direct
Polymerase 2, RNA, subunit K Direct
Polymerase II, RNA, subunit L Direct
RNA polymerase II subunit D Direct
RNA polymerase II subunit G Direct
RNA polymerase IIA 25 kd subunit Direct
TAF15 Direct
RNA polymerase II subunit J Direct
RNA polymerase II, polypeptide H Direct
RNA polymerase II subunit 3 Direct
RNA polymerase II subunit 2 Direct
RNA polymerase IIA 220 kd subunit Direct
Polymerase ii, rna, subunit f Direct
RNA polymerase II associated protein 1 Complex
RNA polymerase II subunit 2
RNA polymerase II subunit D Complex
RNA polymerase IIA 25 kd subunit
Polymerase II, RNA, subunit F
RNA polymerase II subunit G
RNA polymerase II, polypeptide H
Polymerase 2, RNA, subunit K
Polymerase II, RNA, subunit L
RNA polymerase II subunit J
RNA polymerase II subunit I
BRCA1
RNA polymerase IIA 220 kd subunit
RNA polymerase II subunit 2
DNA-binding protein
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Table S3 Continued
Gene name Interactors Type of interaction
MCM3 Cyclin dependent kinase 2 Direct
MCM6 Direct
MCM7 Direct
Minichromosome maintenance protein 2 Direct
Origin recognition complex subunit 2 Direct
Polo like kinase Direct
RNA polymerase IIA 220 kd subunit Direct
MCM5 Direct
Minichromosome maintenance 3 associated protein Direct
ORC5 Direct
MCM4 Direct
Origin recognition complex, subunit 4 Direct
CDC45 Direct
Cell division cycle 7 Direct
Activator of S phase kinase Direct
Coiled-coil domain containing 5 Direct
RAD52 Direct
Minichromosome maintenance protein 10 Direct
CDC6 Direct
CDC5 Direct









RuvB like 2 (*) Direct
C20orf20 protein Direct
HIV-1 Tat interacting protein, 60kDa Complex
Actin beta
Mortality factor 4 like 2
HIV-1 Tat interacting protein, 60kDa
Inhibitor of growth family member 3
Glioma ampliﬁed sequence 41
Bromodomain containing 8
350/400kDa PCAF associated factor
Actin-like 6A
DMAP1
E1A binding protein p400
Mortality factor 4 like protein 1
Sarcoma antigen NY-SAR-91
EPC1
Heat shock 70 KD protein 1A
Ribosomal L1 domain containing 1
C20orf20 protein
RuvB like 2 (*)
HIV-1 Tat interacting protein, 60kDa Complex
Actin beta
Mortality factor 4 like 2
HIV-1 Tat interacting protein, 60kDa
Inhibitor of growth family member 3
Glioma ampliﬁed sequence 41
Bromodomain containing 8
350/400kDa PCAF associated factor
Actin-like 6A
DMAP1
E1A binding protein p400
Mortality factor 4 like protein 1
Sarcoma antigen NY-SAR-91
EPC1
Heat shock 70 KD protein 1A
Ribosomal L1 domain containing 1
C20orf20 protein
RuvB like 2 (*)
Mortality factor 4 like protein 1 Complex
Sarcoma antigen NY-SAR-91
Inhibitor of growth family member 3
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Table S3 Continued
Gene name Interactors Type of interaction
RuvB like 2 (*)
EPC1
Enhancer of polycomb homologue 2
HIV-1 Tat interacting protein, 60kDa
Actin beta
HIV-1 Tat interacting protein, 60kDa
Glioma ampliﬁed sequence 41
Bromodomain containing 8
350/400kDa PCAF associated factor
Actin-like 6A
DMAP1
E1A binding protein p400
RNA polymerase II subunit 5-mediating protein Complex
RuvB like 2 (*)
BCR downstream signaling 1
S phase kinase associated protein 2
NHP2 like protein 1 Complex
Nucleolar protein NOP5
RuvB like 2 (*)
Fibrillarin




NCL Autoantigen La (*) Direct
Casein kinase II, alpha 1 Direct
Casein kinase II, alpha 2 Direct





Protein kinase C, zeta Direct
Telomere reverse transcriptase Direct
c-Myb Direct
p53 Direct
Fragile X mental retardation 1 protein Direct
Staufen Direct
Calgizzarin Direct
PPAR gamma coactivator 1 Direct
Protein phosphatase 2C delta isoform Direct
Myb-related protein A Direct
CD3E Direct
Centaurin, alpha 1 Direct
Splicing factor arginine/serine rich 12 Direct
FXR1 Complex
FXR2
Cytoplasmic FMR1 interacting protein 1
Cyclin T1 Complex
PPAR gamma coactivator 1
Cleavage and polyadenylation speciﬁcity factor 2
RNA polymerase IIA 220 kd subunit
Cyclin dependent kinase 9
TATSF1 Complex
Polymerase II, RNA, subunit F
SUPT5H












Ribosomal phosphoprotein large P0
DDX5
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Table S3 Continued
Gene name Interactors Type of interaction
Ribosomal protein L7a
Tubulin alpha 1




















Switch associated protein 70
ADP ribosyl transferase
PRPF31 None
SNRPD2 EGF receptor Direct
Small nuclear ribonucleoprotein polypeptide D1 Direct
Survival of motor neuron 1, telomeric Direct
Small nuclear ribonucleoprotein polypeptide D2 Direct
Syntaxin binding protein 2 Direct
SMN interacting protein 1 Direct







Survival of motor neuron 2, centromeric Direct
Syntaxin binding protein 3 Direct
Methylosome protein 50 Direct
HIV-1 Tat interacting protein, 60kDa Direct
Gemin 7 Direct
Small nuclear ribonucleoprotein polypeptide E Complex
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide E Complex
YB-1
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
Small nuclear ribonucleoprotein polypeptide F
Small nuclear ribonucleoprotein polypeptide G
Splicing factor, arginine/serine-rich 7
Programmed cell death 7
Chromosome 16 open reading frame 33
Small nuclear ribonucleoprotein polypeptide E Complex
U2AF1L2
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
DDX15
Small nuclear ribonucleoprotein polypeptide F
Small nuclear ribonucleoprotein polypeptide G
Splicing factor 3B subunit 1
Pre mRNA branch site protein p14




Small nuclear ribonucleoprotein polypeptide E
Small nuclear ribonucleoprotein 70 kD
CD2
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Table S3 Continued
Gene name Interactors Type of interaction
Survival of motor neuron 1, telomeric
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
U1 snRNP protein C
Small nuclear ribonucleoprotein polypeptide F
Small nuclear ribonucleoprotein polypeptide G






DNA topoisomerase II alpha
Ribosomal protein S25
Ribosomal protein L12
Small nuclear ribonucleoprotein polypeptide A
RBMX
Splicing factor, arginine/serine rich 1
Splicing factor, arginine/serine rich 2
DNA dependent protein kinase catalytic subunit
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
CDC5
Interleukin enhancer binding factor 2
Ribosomal protein S16
Protein phosphatase 2C delta isoform
Ribosomal protein L13
Splicing factor 3 subunit 1
Spliceosome associated protein 145











DNA topoisomerase II alpha
Ribosomal protein S25
Ribosomal protein L12
Small nuclear ribonucleoprotein polypeptide A
RBMX
Splicing factor, arginine/serine rich 1
Splicing factor, arginine/serine rich 2
DNA dependent protein kinase catalytic subunit
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
CDC5
Interleukin enhancer binding factor 2
Ribosomal protein S16
Protein phosphatase 2C delta isoform
Ribosomal protein L13
Splicing factor 3 subunit 1
Spliceosome associated protein 145
Serine arginine repetitive matrix protein 1









Heat shock 60 KD protein 1
Small nuclear ribonucleoprotein polypeptide E
SNRPB
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Table S3 Continued
Gene name Interactors Type of interaction
U2AF35
U2AF65
Splicing factor, arginine/serine rich 1
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
DDX15
SMN related protein
U2 small nuclear ribonucleoprotein B
U2A prime
Small nuclear ribonucleoprotein polypeptide F
Small nuclear ribonucleoprotein polypeptide G
High mobility group protein 20B
Heat shock protein, 75 kDa








Heat shock 60 KD protein 1




Splicing factor 3A, subunit 2
Splicing factor, arginine/serine rich 1
Small nuclear ribonucleoprotein polypeptide D3
Small nuclear ribonucleoprotein polypeptide D1
DDX15
SMN related protein
U2 small nuclear ribonucleoprotein B
U2A prime
Small nuclear ribonucleoprotein polypeptide F
Small nuclear ribonucleoprotein polypeptide G
High mobility group protein 20B
Heat shock protein, 75 kDa
Splicing factor 3 subunit 1
Splicing factor, 45 kd
Pre mRNA branch site protein p14
Spliceosome associated protein 145
Splicing factor 3A, subunit 3
Splicing factor 3B, subunit 3




PPP2R1A Glutamate receptor ionotropic, N-methyl D-aspartate 1 Direct
Heat-shock transcription factor 2 Direct
NMDAR2D Direct
Protein phosphatase 2, regulatory subunit B (B56), alpha Direct
Protein phosphatase 2, regulatory subunit B’, alpha Direct
Protein phosphatase 5 catalytic subunit Direct
Protein phostase 2A regulatory subunit,48kD Direct
Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 Direct
Importin 9 Direct




Cytoplasmic FMR1 interacting protein 1
Ubiquitin speciﬁc protease 7
KIAA0802
Dedicator of cytokinesis 7
Rho guanine nucleotide exchange factor 2
Protein kinase C, iota type
TGFB1 induced anti apoptotic factor 1
Hypothetical protein KIAA0889
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Table S3 Continued
Gene name Interactors Type of interaction




Ring ﬁnger protein 41
Protein phosphatase 2A, catalytic subunit, beta isoform
14-3-3 zeta
14-3-3 Eta (*)
Chromosome 6 open reading frame 69
Translation regulator protein
EEF1B2 Histidyl-tRNA synthetase Direct
Casein kinase II, alpha 2 Direct
Casein kinase II, alpha 1 Direct
Alanyl tRNA synthetase Direct
Elongation factor 1 alpha 1 Complex
Eukaryotic translation elongation factor 1,delta
Eukaryotic translation elongation factor 1 gamma
Valyl tRNA synthetase 2 Complex
Elongation factor 1 alpha 1
Eukaryotic translation elongation factor 1,delta
Elongation factor G 1
Auxiliary transport protein
GDI2 RAB8 Direct
Ras associated protein RAB9 Direct
Ras associated protein Rab2 Direct
Ras associated protein Rab4 Direct
Ras related protein Rab 5A Direct
Ras family, member rab 11A Direct
Receptor signalling complex scaffold protein
YWHAE ASK1 Direct
Ataxin 1 Direct




Cyclin dependent kinase inhibitor 1B Direct





Kinesin family member 1C Direct
MAP3K10 Direct
Mitogen-activated protein kinase kinase kinase 3 Direct
NGFR associated protein 1 Direct
PCTAIRE protein kinase 1 Direct
Potassium channel, voltage gated subfamily H, member 2 Direct
RAF1 Direct
Regulator of G protein signaling 3 Direct
SHC Direct
Synuclein alpha Direct




Zinc ﬁnger protein A20 Direct
c-Src Direct
Retinitis pigmentosa GTPase regulator Direct
Histone deacetylase 4 Direct
RAS inhibitor 1 Direct
Nude like protein Direct
Ras protein speciﬁc guanine nucleotide releasing factor 1 Direct
Histone deacetylase 5 Direct
TAZ Direct
MAP3K2 Direct
Poly A polymerase alpha Direct
Rho guanine nucleotide exchange factor 2 Direct
REM1 Direct
Rho guanine nucleotide exchange factor Direct
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Table S3 Continued
Gene name Interactors Type of interaction
Tuberous sclerosis 1 gene Direct
Nuclear receptor corepressor 2 Direct
Cell division cycle 2 like 1 Direct




Insulin receptor substrate 4
WD repeat domain 6















YWHAQ CDC 25B Direct
Calpain 3 Direct
Follicle stimulating hormone receptor Direct






6-phosphofructo-2 kinase/fructose-2,6-biphosphatase 2 Direct




Casein kinase 1, alpha 1 Direct
Myocyte speciﬁc enhancer factor 2D Direct
Cyclin dependent kinase inhibitor 1B Direct
Mtor Direct
Kinesin light chain 2 like Direct
Uncoupling protein 2 Direct
Uncoupling protein 3 Direct
SH3 domain binding protein 2 Direct
Regulator of G protein signaling 3 Direct
ASK1 Direct
Regulator of G protein signaling 7 Direct
Tubulin, alpha 2 Direct
MAGOH Direct
Phosphatidylinositol 3-kinase, catalytic beta Direct
Ubiquitin speciﬁc protease 8 Direct
BCL2 antagonist of cell death Direct
Icln-binding protein, 72 kd Direct
3 Phosphoinositide dependent protein kinase 1 Direct
Protein kinase C, mu Direct
Lysosomal trafﬁcking regulator Direct
Keratin 9 Direct
DDX48 Direct
Heat shock 70kDa protein 8 Direct
Kinesin family member 5B Direct
NFAT3 Direct
Yes associated protein Direct
Phosphatidylinositol 4 kinase catalytic beta polypeptide Direct
Methylosome protein 50 Direct
REM1 Direct
Tuberous sclerosis 1 gene Direct
Calcineurin binding protein 1 Direct
Cell division cycle 2 like 1 Direct
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Table S3 Continued
Gene name Interactors Type of interaction
HS1 binding protein Direct
B-Raf Complex
RAP1 GTPase activating protein 1














AP3S1 IRS 1 Direct
SCARB2 Direct
Adaptor related protein complex 3, beta-2 subunit Direct
Clathrin adaptor complex AP3, sigma 3B subunit Direct




Transmembrane receptor protein tyrosine kinase protein
FGFR2 Calcium channel voltage dependent, L type alpha 1D subunit Direct
Fibroblast growth factor 1 Direct
Fibroblast growth factor 5 Direct
Fibroblast growth factor 7 Direct
Phospholipase C, gamma 1 Direct
Fibroblast growth factor 2 Direct
Integrin alpha 5 Direct
Fibroblast growth factor receptor 2 Direct
Fibroblast growth factor 9 Direct





PIP5K2B Tumour necrosis factor receptor 1 Direct
Phosphatidylinositol-4-phosphate 5-kinase type II beta Direct
PIP5K2C None
Heterotrimeric G-protein GTPase protein
GNB4 Guanine nucleotide binding protein, gamma 13 Direct
Guanine nucleotide binding protein, gamma 12 Direct





Calcium-binding protein (signal transduction)
S100A8 Neutrophil cytosolic factor 2 Direct
S100 Calcium binding protein A9 Direct
Carcinoembryonic antigen related cell adhesion molecule 3 Direct
S100 Calcium binding protein A8 Direct
S100A9 S100 Calcium binding protein A8 Direct
S100 Calcium binding protein A9 Direct
Enzyme: dehydrogenase
GAPDH Actin beta Direct
Amyloid beta A4 protein Direct
Calcyclin Direct
Solute carrier family,member 1 Direct
Glyceraldehyde 3 phosphate dehydrogenase Direct
Huntingtin Direct
Diphosphoglycerate mutase Direct
Protein kinase C, iota type Direct
Phosphoglycerate kinase 1 Direct
Androgen receptor Direct
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Table S3 Continued
Gene name Interactors Type of interaction
Ataxin 1 Direct
Dynein light chain 1 Direct
Phospholipase D2 Direct
Metabotropic glutamate receptor 1 Direct
Protein disulﬁde isomerase A2 Direct
HIV-1 Tat interacting protein, 60kDa Direct
SIAH-1 Direct
MDH2 Citrate synthase Direct
Fumarase Direct
Glutamate oxaloacetate transaminase, mitochondrial Direct
Malate dehydrogenase mitochondrial Direct
NADH ubiquinone oxidoreductase Fe-S protein 1 Direct
Pyruvate carboxylase Direct
Enzyme: synthase
PTS BRG1 associated factor,180 KD Direct
6 pyruvoyl tetrahydrobiopterin synthase Direct
Fibronectin type III domain containing 5 Direct
Protein kinase cGMP dependent Type II Direct
Unknown
LSM14 None
DRG1 Leukemia lymphoid 1 Direct
T cell acute lymphocytic leukemia 1 Direct
HCCA2 Serine/threonine protein kinase 38 Direct
NDRG family member 2 Direct
C20orf11 None
SMAD9 Activin A receptor, type I Direct
BTG2 Direct
Bullous pemphigoid antigen 1 Direct
HEY1 Direct
Leucyl cystinyl aminopeptidase Direct
Ribosome binding protein 1 Direct
Small nuclear ribonucleoprotein 70 kD Direct
Upstream regulatory element binding protein 1 Direct
TOB1 Direct
SMAD4 Direct
SMAD, mothers against DPP homologue 2 (Drosophila) Direct
Low density lipoprotein receptor related protein 5 Direct
MLL2 Direct
Hypothetical protein FLJ32214 Direct
Splicing factor 3B subunit 1 Direct
Potential carboxypeptidase like protein X2 Direct
Exophilin 5 Direct
Regulatory factor X 1 Direct
MAN antigen 1 Direct
Zinc ﬁnger and SCAN domain containing 4 Direct
E4F transcription factor 1 Direct
Hypothetical protein KIAA0226 Direct
SECIS binding protein 2 Direct
Aryl hydrocarbon receptor nuclear translocator Direct
Chorionic somatomammotropin hormone 1 Direct
Zinc ﬁnger protein 484 Direct
Zinc ﬁnger protein 587 Direct
Rho GTPase activating protein 9 Direct
Plakophilin 2 Direct
Proline glutamic acid leucine-rich protein 1 Direct
Granulin Direct





BiP associated protein Direct
TID 1 Direct
Dickkopf 1 Direct
Poly(A) binding protein 4 Direct
Plectin 1 Direct
Lipocalin 7 Direct
Ubiquitously transcribed TPR protein on the X chromosome Direct
EIF3S8 Direct
Protein phosphatase 2 regulatory subunit B (B56) epsilon Direct
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Table S3 Continued
Gene name Interactors Type of interaction
KIAA0804 Direct
RAN binding protein 9 Direct
Hairy/enhancer-of-split related with YRPW motif-like Direct
SH2 domain binding protein 1 Direct
MLLT2 Direct
XPA binding protein 2 Direct
TRIM29 Direct
Minichromosome maintenance 3 associated protein Direct
Peroxisome proliferator activated receptor, delta Direct
EIF3S5 Direct
Bromodomain adjacent to zinc ﬁnger domain 1A Direct
Zinc ﬁnger protein 592 Direct
Hypothetical protein FLJ20313 Direct




LIM domain only 4 Direct
Fodrin beta Direct
Ubiquilin 1 Direct
Hypothetical protein FLJ13910 Direct
Phosphorylase kinase liver alpha 2 subunit Direct
DnaJ homologue subfamily C member 7 Direct
Tubulin speciﬁc chaperone D Direct
14-3-3 theta Direct
Ferritin light chain Direct
Patatin like phospholipase domain containing 2 Direct
Cisplatin resistance associated Direct
PI3 kinase related kinase SMG1 Direct
Ubiquitin protein ligase E3A Direct
DIAPH3 Direct
Cytochrome P450, subfamily XIA Direct
SKD3 Direct
Zinc ﬁnger protein 83 Direct
MGAT1 Direct
Adaptor related protein complex 2 alpha 1 subunit Direct
ASB2 Direct
Alpha mannosidase B Direct
Smooth muscle cell associated protein 1 Direct
Methyl CpG binding domain protein 1 Direct
SMAD3 Direct
Pregnancy associated plasma protein A Direct
Glutaminyl tRNA synthetase Direct
Ataxin 1 ubiquitin like interacting protein Direct
Chromosome 9 open reading frame 13 Direct
Pirin Direct
Stromal antigen 1 Direct
Centrosome protein 4 Direct
Limbin Direct
CXXC ﬁnger 5 Direct
Thyroid hormone receptor interactor 12 Direct
Actin beta Direct
Zinc ﬁnger protein 557 Direct
Destrin (actin depolymerizing factor) Direct
ARID1B Direct
Mannosidase, alpha, class 1C, member 1 Direct
Eukaryotic translation initiation factor 3, subunit 6 48kDa Direct
Chondroitin polymerizing factor Direct
Ring ﬁnger protein 123 Direct
Elongation factor 1A binding protein Direct
Proteasome 26S subunit, non ATPase 8 Direct
FLI1 Direct
C10orf2 protein Direct
SMAD interacting protein 1 Direct
Telomeric repeat binding factor NIMA-interacting 1 Direct
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